Device for detecting allergen antibodies in liquid sample and method
By designing a transverse diffusion immunoassay chip, utilizing a combination of porous membrane and liquid absorption region, controlling liquid flow, and setting liquid-blocking elements, a simple, rapid, highly sensitive, and stable repeatable detection of various analytes is achieved. This solves the problems of cumbersome operation and low sensitivity in existing technologies, and is suitable for rapid detection in multiple fields.
Patent Information
- Application Number
- PCT/CN2024/071094
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-01-04
- Filing Date
- 2024-01-08
- Publication Date
- 2024-12-05
AI Technical Summary
Existing immunoassay chips based on porous membrane materials are cumbersome to operate for multiple detection indicators, requiring multiple sample additions, and have low sensitivity and poor repeatability. Furthermore, the large size of the markers limits the number of detection items and the sample size, making it difficult to meet the requirements of simplicity, speed, high sensitivity, and stable repeatability.
A transverse diffusion immunoassay chip was designed, which utilizes a combination of porous membrane and liquid absorption region to control liquid flow through capillary action to achieve unidirectional diffusion. Liquid-blocking elements are set to prolong the reaction time, enzyme labeling is used to improve sensitivity, and test units are arranged in an array to achieve simultaneous detection of multiple analytes.
It enables simple, fast, highly sensitive, and stable repeatable detection of a variety of analytes, reducing sample volume requirements. It is suitable for rapid testing in homes or professional institutions and is applicable to fields such as medicine, veterinary medicine, agriculture, and food safety.
Smart Images

Figure CN2024071094_05122024_PF_FP_ABST
Abstract
Description
Device and method for detecting allergen antibodies in liquid sample
[0001] This application claims priority to the prior Chinese application, application number: 202310616287X, filing date: May 29, 2023. All contents of that application, including but not limited to, the abstract, claims, drawings, and specification are incorporated herein by reference in their entirety as part of this application. Technical Field
[0002] The present invention relates to the field of in vitro diagnostic testing, and in particular to an immunoreaction chip for detecting analytes in a liquid sample based on lateral flow and a method of using the chip. Background Art
[0003] Immunological analysis methods are widely used in the detection of trace substances due to their unique specificity, high sensitivity, and operability. They are widely used in medicine, veterinary medicine, agriculture, animal husbandry, food safety, environmental monitoring, biosafety and other fields.
[0004] Utilizing the specific binding principle of antigens and antibodies, simultaneous detection of multiple substances in the same sample is possible. Examples include solid-phase protein microarrays, liquid-phase protein microarrays, membrane strip immunoblotting, microarray enzyme-linked immunosorbent assays, and dot-ELISA. All of these methods require minimal sample volume and offer high throughput, and are being applied to various niche areas, such as allergen detection, autoimmune disease, multiple tumor markers, multiple pathogens, pesticide residues, and natural toxins.
[0005] To date, all immunological testing methods require that the antigens or antibodies involved in the immune reaction be immobilized on a solid surface, such as a flat glass surface, a flat polymer surface, a polymer microsphere surface, or a membrane structure. Some of these detection methods are based on membrane materials and can simultaneously detect multiple analytes. Membranes are essentially porous materials formed by interlaced fibers. These materials possess properties such as the ability to transiently bind large amounts of proteins, chemical inertness, and capillary action. This makes membrane-based immunological testing methods diverse and widely used. Currently, dot-ELISA, Western blotting, flow through immunoassay, and lateral flow immunoassay are the main methods used.
[0006] All immunological reactions require a water-based liquid, where antigens and antibodies specifically bind through collision, ultimately forming immune complexes. When a membrane is used as a solid-phase carrier, the immune reaction primarily occurs at the interface between the solid and liquid phases. The effectiveness of the immune reaction is influenced not only by the concentration of the antigens or antibodies involved in the immune reaction in the liquid phase, the distribution density of the antigens or antibodies involved in the immune reaction on the solid surface, and their affinity, but also by the degree of effective contact between the solid and liquid phases.
[0007] In practical applications, a detection method must simultaneously meet the requirements of high sensitivity, stable repeatability (precision), and simplicity and speed. Therefore, it needs to be rationally designed based on the principles of the immune response described above. However, the main current methods all have some inherent drawbacks.
[0008] In dot-ELISA and immunoblotting, the membrane acts as a solid-phase carrier, primarily immobilizing the antigen or antibody. When a liquid is added to the membrane, the primary reaction between the solid and liquid phases occurs at the membrane surface, where the liquid is in contact. The membrane's inner surface has relatively weaker contact with the liquid. This relatively weak contact prevents the antigen or antibody immobilized within the membrane from reacting quickly with the corresponding antibody or antigen in the liquid phase. Consequently, in practical applications, a longer incubation time is required to achieve a sufficient immune reaction between the antigen and antibody, typically exceeding 30 minutes, and additional oscillation and heating are required to increase the movement of the antigen or antibody in the liquid phase. This increased incubation time due to inefficient collisions and the addition of external forces and ambient temperature also increases the risk of nonspecific binding. A common solution currently employed is to increase the intensity of washing after the immune reaction, such as by soaking the sample in a detergent solution for a long time, oscillating the sample, and performing repeated washing, for example, soaking for 5 minutes and then washing the sample three or more times. This further reduces the convenience of this detection method. Currently, detection methods using this mode require several hours and require the introduction of multiple auxiliary measures and complex operations to obtain results. For example, some equipment must be used to complete the process (such as heating equipment, mechanical vibration equipment, etc.).
[0009] In the immunofiltration method, the membrane also serves as a solid phase to immobilize the immunoelement. The liquid used in each step of the immune reaction passes perpendicularly through the membrane plane. The analyte in the liquid is filtered through the membrane by gravity and the capillary action of the absorbent material beneath the membrane. Once the filtration is complete, the analyte is captured by the antigen or antibody immobilized on the membrane. Next, labeled antigen or antibody is added dropwise. Again, gravity and the capillary action of the absorbent material beneath the membrane drive the labeled antigen or antibody to bind to the captured analyte, forming an immune complex. This method uses a small-pore membrane, such as 0.45μm or 0.22μm nitrocellulose, to increase the density of the immobilized antigen or antibody. However, due to the extremely rapid filtration rate, the time for the immune reaction between the immobilized antigen or antibody, the analyte, and the labeled antigen or antibody to collide is too short, making it difficult to ensure efficient immune complex formation. This results in low sensitivity. Furthermore, the speed at which the liquid passes through the membrane is affected by the tightness of the absorbent material to the membrane, resulting in poor reproducibility of the amount of immune complex formed. This limits the application of this method.
[0010] In immunolateral chromatography, the porous nature of the membrane allows capillary diffusion to act as the driving force when it comes into contact with the liquid phase, allowing the liquid containing the sample and labeled antigen or antibody to flow through the fixed paired antigen or antibody in the detection area, triggering an immune reaction. The remaining liquid is then continuously absorbed by the wicking material, which acts as the driving force, ultimately completing the flow of the liquid through the detection area. The formation of immune complexes leads to the accumulation of labeled substances in the detection area, which is related to the presence and amount of the analyte. Labeling materials used include colloidal gold, latex particles, fluorescent microspheres, and quantum dots. All current labeling technologies used in immunolateral chromatography suffer from a limited number of analytical items, namely, the number of assays tested is limited. Currently, a single reagent strip can only detect three analytes, which is the maximum limit. The fundamental reason for this is that the immune complex amplification method used in this model is essentially physical amplification. To increase detection sensitivity, all current markers are larger than the molecular scale of the labeled substance (for example, antibody molecules in liquids are approximately 6 nm, while colloidal gold markers are typically over 40 nm, and latex microspheres are 200 nm). The detection area that the flow passes through later is affected by the degree of marker accumulation in the detection area that the flow passes through earlier. Typically, a single immunochromatographic device detects no more than three items. In addition to the aforementioned inter-item influence, the main reasons include the large microscopic size of the markers themselves, and the limited total amount of markers carried in the device. The current common solution is to prepare separate test strips capable of detecting one or a small number of analytes, and then assemble multiple test strips into a single plastic card holder, such as for urine drug abuse testing. This solution essentially involves combining multiple detection reagents, requiring a multiplied sample volume, and therefore can only measure a few analytes.
[0011] Existing immunoreaction chips based on porous membrane materials often use multiple independent measurement points when measuring multiple detection indicators. The test liquid is dripped onto each independent measurement point for immune reaction. This method will have some problems: when measuring too many detection indicators, the operation is cumbersome and the sample amount required is large; and when the sample concentration is too high or too low, the measurement results may be inaccurate.
[0012] Therefore, there is an urgent need to find an immunoreaction detection method based on porous membrane materials that is simple, fast, highly sensitive, and has stable repeatability (precision) for the simultaneous analysis of multiple analytes.
[0013] Summary of the Invention
[0014] To address the problems existing in the above-mentioned conventional technologies, the present invention provides a chip element and method for use in measuring analytes in samples using biological materials. The method of the present invention can simultaneously measure multiple analytes, and is simple to operate. It is suitable for home testing such as OCT, as well as for testing by professional institutions. Furthermore, the number of analytes tested can exceed three, and the sample size required is very small. The testing device and method of the present invention are particularly effective in situations where 10-100 different analytes need to be tested at once, and the sample size is limited.
[0015] On the one hand, the present invention provides a testing device for detecting an analyte in a liquid sample. The device includes a testing area and a liquid absorption area fluidically connected to the testing area. The liquid absorption area can absorb a large amount of liquid from the testing area multiple times, allowing different liquids to flow through the testing area, thereby completing the analysis or test of the analyte.
[0016] In some methods, the test area is set or arranged on a porous material, and the porous material itself has a water-absorbing property. This water-absorbing property mainly relies on capillary action to absorb liquid or allow liquid to move on the porous material. In some methods, when the porous material itself is wetted, or when the porous material itself loses its capillary force, if you want to continue to allow different types of liquids to flow on the porous material, you need to rely on the capillary force of the absorption area to allow different types of liquids to flow through the porous material and pass through the test area, thereby completing the test of the analyzed substance. The diffusion rate of this liquid can be controlled more accurately. In some methods, the direction of liquid diffusion in the porous material can be controlled; in some methods, the direction of liquid flow on the porous film is unidirectional, and multiple liquids flow in the same single direction at different times.
[0017] The present invention overcomes the shortcomings of the prior art by leveraging the principle of immune complex formation, the solid-liquid interface characteristics between the fiber membrane and the liquid, and the method for converting the formed immune complex into an observable signal. The invention designs a unidirectional lateral diffusion immune response chip element and corresponding methods of use. This immune response chip and method of use are not only rapid and simple, highly sensitive, and reproducible, but also enable simultaneous qualitative and quantitative analysis of multiple indicators. This method is not only suitable for manual operation but can also be automated using simple instruments. The immune response chip herein has the same meaning as the "device" described in the present invention.
[0018] In some embodiments, the test area on the porous membrane has multiple test units, each targeting a specific analyte, or multiple test units can test for multiple different analytes. In some embodiments, multiple test units are distributed in an array on the porous membrane, with these multiple test units forming a single test area. In some embodiments, each test area is immobilized with a first receptor that specifically captures only a specific analyte in the sample, such as an antibody or antigen. In some embodiments, this receptor can bind to another binding element, such as biotin, but this receptor can only bind to a single analyte in the sample. When multiple test units are each immobilized with a first receptor, an array of multiple first receptors is formed, each of which can specifically bind to a specific analyte in the sample, allowing simultaneous detection of multiple analytes in the same sample. In this test, the liquid sample flows across the porous membrane, either through the porous membrane itself or through the porous membrane in conjunction with a water-absorbing area. This flow occurs in a transverse, uniform direction. In some ways, in addition to the flow of the liquid sample itself, other types of liquids can also be allowed to flow on the porous film, participating in the entire test process, and ultimately completing the determination of the presence or quantity of the analyzed substance. In some ways, multiple fixed binding sites are set inside the porous film, for example, multiple first receptors are fixed, and the multiple points can be arranged side by side or front and back or form an array, which will not affect the detection of each binding point. In this way, the sample can be added once, and the liquid to be tested flows through all binding sites in turn, producing the effect of multiple detection indicators. In some ways, the test units can be arranged on the test area in any form, or spaced apart from each other, or arranged in any shape, such as circle, square, trapezoid, rhombus, etc.
[0019] In some embodiments, in addition to the liquid sample, other liquids are also included, such as but not limited to, one or more cleaning liquids, a blocking liquid containing a blocking reagent, a second receptor solution, and a reaction solution that can react with a marker substance. These cleaning liquids can include cleaning liquids with multiple different purposes. For example, after the liquid sample flows through a porous membrane, the cleaning liquid is then passed through the porous membrane to remove residual liquid sample or residual impurities, etc. In some embodiments, after the second receptor solution passes through the porous membrane, another cleaning liquid can be passed through the porous membrane to clean away the residual second receptor. In some embodiments, there can also be multiple cleaning liquids and multiple second receptor solutions. In some embodiments, there can also be a reaction solution, which contains a reaction reagent that reacts with the marker substance on the immune complex fixed on the test unit to produce a signal substance. After the signal substance is produced, it can still be cleaned with a cleaning liquid to remove the residual substance. These liquids include, but are not limited to, liquid samples, mixtures of samples and sample diluents, washing solutions, liquids containing enzyme-labeled antigens or antibodies, liquids containing small molecule-labeled antigens or antibodies, liquids containing enzyme-labeled ligands that specifically bind to small molecules, reaction solutions, and combinations or mixtures of the above various liquids of blocking solutions. In some embodiments, the various liquids are pre-stored in a multi-cavity structure, and when a reaction is required, the end of the test device for receiving the liquid is inserted into the cavity to contact different liquids. Of course, automated operations can also be used to allow the test card to automatically be inserted into each cavity to contact different liquids.
[0020] Of course, the blocking solution is intended to block the blank areas on the porous membrane or the test cell, reducing the occurrence of false positives. In some approaches, the blocking solution contains a blocking reagent, which is primarily used to block certain sites on the porous membrane, preventing them from binding to the second receptor. These sites can be sites in the blank areas or sites on the test cell. In some approaches, the second receptor in the second receptor solution specifically binds to the analyte captured by the first receptor. Specific binding here means that the binding efficiency of the second receptor with the analyte is higher than the binding efficiency of the second receptor with other substances. For example, if the binding efficiency of the complex formed by the first receptor and the analyte to the second receptor is 100%, then the second receptor is 100% incapable of binding to other substances, such as other complexes or other analytes. If the binding efficiency is 95-99%, then the second receptor has only a 5-1% chance of binding to other substances, such as other complexes or other analytes. The specific binding efficiency here can be 100% or above.
[0021] In some approaches, the second receptor can specifically bind to the analyte. In some approaches, the second receptor can specifically bind to a specific site on a complex. For example, the second receptor can specifically bind to the first receptor, or to a portion of a site on a complex formed by the first receptor and the analyte. In some approaches, if the first receptor is an antigen, it can specifically bind to an antibody in the sample, and the second receptor can be an antibody to the antibody in the sample, or other similar receptor that can specifically bind to the antibody in the sample. For example, the first receptor can be the primary antibody of the antibody in the sample, and the second receptor can be the secondary antibody of the antibody in the sample. If it is necessary to detect an antigen in the sample, the first receptor can be the primary antibody of the antigen, and the second receptor can be the secondary antibody of the antigen.
[0022] In some ways, the second receptor also carries a marker substance, and the marker substance can produce a signal with the reaction reagent in the reaction solution, and the presence of the signal indicates the amount of the analyte or the presence of the analyte. In some ways, the marker substance does not need to be in contact with the reaction reagent, but directly carries an intuitive signal, such as color particles, color dyes, or fluorescent dyes, etc. These colored particles can read the test results directly with the naked eye, and if they are fluorescent dyes, they are read by a device that can read fluorescence. For example, the marker substance can also be gold particles, latex particles or water-soluble pigments. When using a marker substance with an intuitive symbol, in some embodiments, a cleaning liquid or a sealing liquid is also needed. These cleaning liquids or sealing liquids can clean the film after the liquid sample flows through the porous film, or the sealing liquid can clean the film after flowing through the film, or the second receptor with the marker substance can clean the film after flowing through the film.
[0023] When a marker substance reacts with a reaction solution to produce a signal, the marker itself does not directly carry the signal; rather, the signal is generated by a reaction with a reagent. This "reaction" can refer to a chemical reaction or the spatial change caused by contact between the reagent and the marker, generating the signal. This signal can be read visually or by a machine. The signal can be a color change, light, electricity, or radiation. Color signals can be the appearance or disappearance of color; light can be a luminescent substance, a change in light wave, or a change in wavelength; electricity can be direct current or alternating current, or the appearance or flow of electrons.
[0024] In some embodiments, the marker substance is an enzyme, and the reaction reagent in the reaction solution contacts the enzyme to produce a colored substance, which is aggregated on the test unit to indicate the presence and amount of the analyte on the test unit.
[0025] In some embodiments, the marker substance is an enzyme, and the reaction reagent in the reaction solution contacts the enzyme to generate fluorescent substances, which are aggregated on the test unit to indicate the presence and amount of the analyte on the test unit.
[0026] In some ways, in order to make it easier for the porous film to contact the liquid and allow the liquid to flow on the film, an area is set on the porous film for contacting the liquid. For example, an area is set upstream of the test area for contacting the liquid, and a water-absorbing area is set downstream of the test area to attract the liquid on the porous film to flow, or the absorption area continuously provides the porous film with capillary force, so that different liquids can pass through the test area from the upstream of the test area and flow to the downstream of the test area many times. It can be understood that several areas are divided on the same porous film, one area is used to receive the liquid, and the other area is in contact with the absorption area, and the test area is set between these two areas. The area for receiving the liquid, the area in contact with the water-absorbing area, and the test area are all located on the porous film of the same material. Of course, it is also possible to select porous films of different materials for the three areas. For example, the test area is located on one porous film, and the area for receiving the liquid can be another porous film that is not used for the test area.
[0027] In some methods, we choose a membrane with a specific pore size for the choice of porous film. When the test liquid reacts with the binding point, an immune complex is produced at the fixed point. We choose a membrane with a larger pore size to ensure that after the immune reaction occurs and the immune complex is produced, the immune complex will not block the membrane channel and will not hinder the unreacted test liquid from continuing to diffuse to the liquid absorption area and react with the subsequent binding points. A plurality of test units are arranged in an array on the film. These test units always contact the liquid first and the last in the direction of liquid flow. If the test unit that contacts the liquid first reacts and blocks the film, the liquid flow rate slows down or the direction of liquid flow is changed, the reaction of the test unit that contacts the liquid later will be incomplete, and some may not contact the liquid, resulting in some test units being able to be effectively tested, while some test units cannot complete effective testing.
[0028] In some methods, the liquid is allowed to pass through the porous membrane as much as possible, while the liquid flowing through the surface of the membrane is minimized. This may cause a "flood" and affect the test results. Therefore, in some methods, we set a liquid-blocking element downstream of the liquid receiving area to prevent the liquid from flowing through the surface of the porous membrane, and instead allow it to pass through the membrane, so that the liquid can fully contact each test unit. In some methods, since the binding point is mainly fixed inside the membrane, this can effectively prevent the liquid reagent from flowing on the membrane surface, and then concentrate the diffusion in the capillary channels inside the membrane, which can increase the efficiency of the immune complex formation at the binding point and increase the accuracy and sensitivity of the test.
[0029] In some methods, a liquid-blocking element can also be set downstream of the test area to reduce the flow rate of the liquid, allowing the liquid to stay on the porous membrane for a longer time. It also has the effect of allowing the liquid to pass through the membrane as much as possible to reach the absorption area, allowing the absorption area to rely on capillary action as much as possible to absorb the liquid from the porous membrane, and avoiding allowing the liquid to flow through the surface of the membrane to the water-absorbing area.
[0030] In some embodiments, a liquid barrier is positioned downstream of the liquid receiving area and upstream of the testing area, as well as downstream of the testing area and upstream of the water absorption area. This allows the liquid to pass through the membrane as much as possible while minimizing its flow across the membrane surface. It also allows the liquid to spend more time within the membrane and in contact with multiple test cells, which is particularly important when testing multiple analytes at once. When multiple test cells are involved, such as those testing 10-100 different analytes, these test cells must contact the liquid in a certain order. Allowing the liquid to pass through the membrane allows the liquid more opportunities to contact each test cell, thereby improving testing efficiency.
[0031] In some other embodiments, when the liquid is received by one end of the film, it flows through the test area on the porous film and eventually flows to the absorption area downstream. For example, these liquids can be liquid samples, cleaning fluids, second receptors containing marker substances, and reaction liquids, etc. However, in some cases, only relying on the time for the liquid to flow through the porous film to test different test units, although the test can be performed, the effect is not ideal. It is hoped that the liquid can stay on the porous film for a long time, so that the liquid can fully contact with each test unit and fully react. Therefore, the liquid-blocking element of the present invention has such a function, particularly the liquid-blocking element arranged downstream of the test area, which can prevent the liquid from flowing quickly to the water-absorbing area and allow it to stay on the porous film for a long time.
[0032] In some embodiments, the liquid-blocking element encloses the test area on the porous membrane to form a specific area, such as a water reservoir or liquid reservoir. Liquid can be dripped directly from the porous membrane into the reservoir, maintaining a certain height on the porous surface. This allows the liquid in the reservoir to simultaneously cover all test cells. In some embodiments, the liquid is a solution containing a reagent that reacts with the marker. This allows the reagent to remain in contact with the marker for a longer period of time to allow the marker to fully react and consume, resulting in more accurate results. This time is longer than when the reaction liquid enters from one end of the porous membrane and exits the test area downstream. In some embodiments, while the liquid is in the reservoir formed by the liquid-blocking element, the water-absorbing area maintains its ability to absorb water from the porous membrane, and the liquid in the reservoir also flows into the water-absorbing area due to capillary action in the water-absorbing area. This means that while the reaction liquid contacts and reacts with the multiple test cells on the test area, it also continuously flows through the porous membrane into the water-absorbing area. Once the reaction liquid is completely absorbed by the water-absorbing area, the reaction is essentially complete. The reaction time of the reaction solution can be determined depending on the amount of the reaction solution.
[0033] In some approaches, the labeling agent is an enzyme, and the second receptor is labeled with the enzyme. When the enzyme-labeled second receptor binds to the first receptor and the analyte to form a complex, specifically binding, the labeled enzyme is also incorporated into the immune complex and immobilized on the test unit. After the reaction in the reaction zone is complete, the remaining enzyme-labeled second receptor can be cleaned with a detergent. A reaction solution corresponding to the labeled enzyme is then added. When the reaction solution comes into contact with the enzyme-labeled immune complex, it is catalyzed by the enzyme, producing a substance visible under visible light, a fluorescent substance, or a dimly luminescent substance. This can be observed visually or by using a sensor to measure the fluorescence and dimly luminescent signals. In some approaches, the reaction solution can be added directly to the pool formed by the liquid barrier element for reaction. In some approaches, the liquid barrier element is a hydrophobic polymer plastic sheet coated with a thin layer of adhesive. Suitable materials include, but are not limited to, polyvinyl chloride (PVC), polyester (PET), and polystyrene (PS) sheet profiles. The liquid barrier element is adhered to the surface of the porous film using an adhesive. In some approaches, the liquid barrier itself has a certain degree of elasticity, which is adjusted by the material and adhesive, ensuring a tight fit with the housing and eliminating the risk of liquid leakage. In some approaches, the liquid barrier is implemented by the window areas of the upper and lower cards of the test card, rather than a separate liquid barrier.
[0034] In some approaches, if the enzyme is considered a sphere, the size of the labeled enzyme is related to the molecular weight of the enzyme itself. For example, horseradish peroxidase (HRP), with a molecular weight of approximately 40 kD, has a molecular diameter of approximately 4 nm; recombinant alkaline phosphatase (AP), with a molecular weight of approximately 80 kD, has a molecular diameter of approximately 5 nm. If the immune complex is formed as membrane-antigen-antibody (analyte)-antibody (antibody to the analyte)-enzyme, the thickness of the antibody-antibody-enzyme complex relative to the membrane-antigen increases by only approximately 16 nm, far less than the membrane pore diameter of 8 μm (8000 nm). The resulting enzyme-labeled immune complex does not block the membrane's internal channels, nor does it hinder the continued diffusion of the test liquid reagent to react with subsequent binding sites.
[0035] The 8μm membrane pore size described above is measured using an electron microscope. In practical applications, the lateral flow rate of liquid through the membrane can be used as a criterion for determining membrane size. Membrane pore size is inversely proportional to the time it takes for liquid to diffuse laterally per unit distance within the membrane. For an 8μm membrane, liquid diffuses laterally over a distance of 4cm in approximately 140 seconds. A shorter time indicates a membrane pore size larger than 8μm, while a shorter time indicates a membrane pore size smaller than 8μm.
[0036] In some embodiments, the present invention provides an immunoreaction chip for lateral diffusion detection and its use method. This can avoid some problems in existing technologies. For example, multiple detection indicators require multiple sample additions, while the chip and method provided by the present invention only require a single sample addition, making operation more convenient and suitable for situations where samples are scarce. In addition, the use of enzyme labeling to reflect the progress of the immune response is more intuitive.
[0037] Existing chips cannot utilize this approach primarily because the multiple binding sites can interact with each other. If an immune reaction occurs in the front test area, the subsequent test area will be significantly affected, leading to measurement problems. Even in extreme cases where the binding sites do not interact, liquid may flow away from the surface, resulting in little or no reaction with the binding sites, seriously affecting measurement accuracy. The immunoreaction chip for lateral diffusion detection and its method of use provided by the present invention address these issues, as explained above.
[0038] In some embodiments, the pore size of the porous film is greater than 8 μm. In some embodiments, the material of the membrane applied to the membrane sheet includes but is not limited to nitrocellulose membrane, polyvinylidene fluoride membrane, modified nylon membrane, or polyethersulfone membrane.
[0039] In some embodiments, the water-absorbing region comprises a material capable of absorbing water, including but not limited to cellulose filter paper and cellulose acetate blocks. In some embodiments, the dilution capacity of the water-absorbing region is greater than, or significantly greater than, the water-absorbing capacity of the porous membrane. In some embodiments, the amount of liquid that can be retained by the liquid-absorbing material is significantly greater than the total amount of liquid entering the liquid-inlet region of the membrane and the total amount of reaction liquid entering the reaction region, or the total amount of liquid discharged from the liquid-discharge region of the membrane during a single test.
[0040] In some embodiments, the device further comprises a chamber formed by assembling an upper card and a lower card, which protects the water-absorbing material and a portion of the porous film, leaving only the test area exposed. The test area is exposed through a window in the upper card for reading the test results. In some embodiments, the first receptor or the second receptor may include, but is not limited to, polypeptides, proteins, glycoproteins, lipoproteins, nucleic acids, and protein complexes that bind to nucleic acids, as well as antibodies, antigens, or any other substance that can be used to directly or indirectly detect an analyte in a sample by specific binding.
[0041] Another aspect of the present invention provides a method for testing an analyte in a liquid sample, the method comprising: providing a testing device comprising a porous film and a water-absorbing area in fluid communication with the porous film, wherein the porous film has a first end and a second end, the second end being connected to the water-absorbing area, and testing areas are provided at the first end and the second end of the porous film, the testing area including one or more first receptors for detecting the presence or quantity of one or more analytes in the test sample, contacting the first end of the porous film with the liquid sample, and allowing the liquid sample to flow through the porous film, thereby passing through the testing area, reacting with the first receptors on the testing area to form a complex, and then flowing to the water-absorbing area.
[0042] In some methods, after the first end of the porous membrane is brought into contact with the liquid sample, the first end of the porous membrane is then brought into contact with a second receptor carrying a marker, and the second receptor is allowed to flow along the porous membrane and pass through the test area under the action of the water-absorbing area, and react with the complex in the test area, thereby being fixed on the test area.
[0043] In some embodiments, the reaction solution includes a substance that can be catalyzed by an enzyme to produce chemiluminescence, a fluorescent precipitate, or a chromophore precipitate visible to the naked eye under visible light. In some embodiments, the test area of the present invention employs immunological reaction methods for detecting analytes in samples, including but not limited to one-step sandwich methods, two-step sandwich methods, indirect methods, and blocking competition methods. In some embodiments, the test area may also include methods suitable for hybridization testing, including but not limited to mixed solutions of DNA with the same or complementary sequences amplified by PCR for DNA detection, and mixed solutions of DNA with the same or complementary sequences amplified by inverse PCR for RNA detection. In some embodiments, the immunoreaction chip element reacts with different liquids or liquid reagents to form different intermediates, such as protein-protein complexes, protein-protein-labeled protein complexes, and protein-labeled protein complexes. In some embodiments, in nucleic acid hybridization experiments, the intermediate complexes formed include DNA-DNA-FITC complexes, DNA-DNA-biotin complexes, DNA-DNA-bition-streptavidin-enzyme complexes, and DNA-DNA-FITC-anti-FITC antibody-enzyme complexes.
[0044] In some embodiments, after the first end of the porous membrane is brought into contact with the liquid sample, the porous membrane is then brought into contact with a cleaning solution to remove impurities on the test area or liquid sample remaining on the test area.
[0045] In some embodiments, after the first end of the porous membrane is contacted with the liquid sample, it is sequentially contacted with a first cleaning solution, a solution of a second receptor with a marker, a second cleaning solution, and then a reaction solution, wherein the reaction solution includes a reaction reagent that can react with the marker to generate a signal.
[0046] In some embodiments, after contacting the liquid sample or the first cleaning solution, the first end of the porous membrane is contacted with a blocking solution containing a blocking reagent. In some embodiments, the blocking reagent includes a protein, a polypeptide, or a protein fragment.
[0047] In some embodiments, a liquid-blocking element is disposed upstream of the test area. The liquid-blocking element covers the porous film, exposing a first end of the porous film, thereby forming an end in contact with the liquid. In some embodiments, liquid enters upstream of the liquid-blocking element, passes through the porous film, then through the test area on the porous film, and then flows into the water-absorbing area. The liquid-blocking element allows liquid from the first end to pass through the porous film without flowing over the surface of the porous film.
[0048] In some ways, a second liquid-blocking element is provided between the water-absorbing area and the test area, so that the liquid on the porous film stays on the porous film for a longer time, thereby allowing the liquid to contact the test area for a longer time. Therefore, the second liquid-blocking element is configured to reduce the flow rate of the liquid. The effect of the second liquid-blocking element can also be understood as slowing down the normal flow rate of the liquid. In some ways, the liquid-blocking element applies a certain pressure to the porous film, so that the porous film is compressed, thereby slowing down the flow rate of the liquid thereon, but does not completely cut off the connection between the porous film and the water-absorbing area. In some ways, the water-absorbing area can continue to absorb the liquid from the porous film.
[0049] In some embodiments, the liquid-blocking element encloses a pool area on the porous film, and the test area is located in the pool area. The reaction liquid is directly added to the pool so that the reaction liquid is in contact with the entire test area. In some embodiments, the reaction liquid includes a reaction reagent, and the reaction reagent can react with a marker substance to produce a signal substance. Therefore, in some embodiments, after the second receptor solution with a marker substance passes through the test area, the reaction liquid is directly added to the pool, and the reaction reagent in the reaction liquid is allowed to react with the marker substance fixed on the test area to generate a signal substance. If the marker substance is an enzyme, the reaction reagent can react with the enzyme to generate a signal substance that is a colored precipitate.
[0050] In some methods, the reaction solution is added directly to the cell and allowed to form a layer covering the test area for a period of time, which can range from 10 seconds to 60 minutes. In some methods, while the reaction solution is allowed to remain, the water-absorbing area can continue to absorb the reaction solution from the film, and the retention period is sufficient to allow the water-absorbing area to completely absorb the reaction solution.
[0051] A third aspect of the present invention provides an allergen testing device, comprising: a test area and a water-absorbing area, wherein the test area is configured to directly contact a liquid, and the water-absorbing area is located downstream of the test area and configured to absorb liquid from the test area, allowing the liquid to flow laterally through the test area and onto the water-absorbing area. The test area has immobilized thereon a plurality of first receptors that specifically bind to allergic antibodies in a sample. These first receptors may be first antibodies to allergens or allergic antibodies. These multiple different first receptors bind to multiple different allergen antibodies in the liquid sample. In some embodiments, the test area is located on a porous membrane. In some embodiments, one end of the porous membrane is configured to directly contact the liquid, and the other end of the porous membrane is in contact with the water-absorbing area, allowing the water-absorbing area to absorb liquid from the porous membrane, allowing the liquid to flow from the end of the porous membrane that contacts the liquid, through the test area, to the other end in contact with the water-absorbing area. In some embodiments, the liquid includes one or more of a diluent for dissolving or diluting the liquid sample, a liquid containing a labeling substance, a washing liquid, and a blocking liquid. In some embodiments, the end of the porous membrane that is in direct contact with the liquid can be sequentially contacted with one or more of the following: a liquid sample, a liquid containing a marker, a washing liquid, a blocking liquid, and a reaction liquid capable of reacting with the marker to produce a signal substance. In some embodiments, one end of the porous membrane can be sequentially contacted with the liquid sample, a first washing liquid, a blocking liquid, an antibody liquid containing an anti-allergic antibody containing the marker, a second washing liquid, and a reaction liquid capable of reacting with the marker to produce a signal substance.
[0052] In some embodiments, the liquid containing the marker includes a plurality of different second receptors capable of specifically binding to allergen antibodies (IgE) carrying the marker. The second receptor can be an antibody to the allergen antibody (IgE) or a complex of other antibodies capable of specifically binding to the first receptor and the allergen antibody. The allergen antibodies can specifically bind to different allergen antibodies in the sample. In some embodiments, each of the antibodies carries the same type of marker. In some embodiments, the markers include enzymes, colored particles or dyes, or fluorescent markers, with enzymes being preferred.
[0053] In some embodiments, the device further comprises a liquid-blocking element, which can allow the reaction liquid to remain on the test area on the porous membrane or allow the liquid entering from one end of the porous membrane to pass through the membrane and flow through the test area as little as possible without flowing from the surface. In some embodiments, a first liquid-blocking element is provided between the end of the porous membrane that contacts the liquid and the test area. This element allows the liquid entering from this end to not flow from the surface of the membrane, but to pass through the membrane itself and pass through the test area. In some embodiments, a liquid-blocking element is provided between the downstream of the test area and the water absorption area, thereby slowing down the flow rate of the liquid and allowing the liquid to stay longer on the test area. In some embodiments, the liquid-blocking element encloses a pool area on the porous membrane, the test area is located in the pool area, the reaction liquid is applied to the pool, and the reaction liquid is allowed to contact the test area. In some embodiments, the reaction liquid includes a reaction reagent, which can react with a marker substance to produce a signal substance. Therefore, in some approaches, after a second receptor solution containing a marker passes through the test area, a reaction solution is added to the reservoir. The reaction reagent in the reaction solution reacts with the marker immobilized on the test area to produce a signal substance. If the marker is an enzyme, the reaction reagent reacts with the enzyme to produce a colored precipitate.
[0054] In some embodiments, the liquid-blocking element is essentially composed of a hydrophobic polymer material, including one or more of polyvinyl chloride, polyester, polyurethane, and polystyrene. In some embodiments, the solution for dissolving the liquid sample does not contain a blocking reagent. In some embodiments, the blocking reagent is configured to block the pores in the blank area on the porous film. In some embodiments, the blocking reagent includes casein. In some embodiments, the porous film includes a nitrocellulose membrane or a polyvinylidene fluoride membrane. In some embodiments, the porous film is such that the time required for pure water to diffuse 4 cm along the porous film is less than 5 minutes. In some embodiments, the water-absorbing area includes a water-absorbing pad, and the water-absorbing pad includes a hydrophilic fiber material selected from natural plant fibers or chemically synthesized acetate fibers. In some embodiments, the liquid sample is a serum, plasma, or whole blood sample.
[0055] A fourth aspect of the present invention provides a method for testing allergen antibodies in a sample, the method comprising a method for detecting allergen antibodies in a liquid sample, the method comprising: providing a testing device comprising a testing area and a water absorption area, wherein a plurality of first receptors are fixed in an array on the testing area, each receptor being capable of specifically binding to an allergen antibody in the liquid sample; the testing area being located on a porous membrane, the porous membrane having a first end and a second end, the water absorption area being connected to the first end of the porous membrane, allowing the second end of the porous membrane to contact the liquid sample, thereby allowing the liquid sample to pass through the testing area on the porous membrane and then flow to the water absorption area.
[0056] In some embodiments, the second end of the porous membrane is contacted with a blocking liquid containing a blocking reagent, allowing the blocking reagent to fill the blank areas on the porous membrane or block nonspecific binding sites. In some embodiments, the second end of the porous membrane is contacted with multiple second receptor solutions containing a labeled substance, each of which can specifically bind to an allergen antibody in the sample. This allows the second receptor solution containing the labeled substance to flow through the test area and into the water-absorbing area via capillary action in the water-absorbing area. In some embodiments, the porous membrane also includes an area formed by a liquid-blocking element, which includes the test area. The liquid-blocking element allows the reaction solution to remain in the test area.
[0057] In some embodiments, the reaction liquid is directly applied to the test area, so that the liquid-blocking element can allow the reaction liquid to remain in the test area. In some embodiments, the reaction liquid includes a reaction reagent, and the reaction reagent can react with a marker substance to generate a signal, and the presence or quantity of the analyzed substance is obtained based on the presence or quantity of the signal. In some embodiments, the signal can be read, preferably, it can be read by the naked eye. In some embodiments, when the reaction liquid stays on the test area, the water-absorbing area can simultaneously absorb part of the reaction liquid on the porous film and flow to the water-absorbing area. In some embodiments, the time for the reaction liquid to stay in the test area is 10 seconds to 60 minutes.
[0058] In some embodiments, after the second end of the porous membrane is contacted with the liquid sample, the first end of the porous membrane is contacted with a washing solution and then with a solution containing a labeling substance.
[0059] The beneficial effects of the present invention include:
[0060] 1. The size of the enzyme molecules themselves and the hydrophilic nature of their surface do not affect the diffusion of liquid in the membrane channel. This property allows each fixed immune reaction in the chip reaction area to proceed independently, realizing the effect of two-dimensional detection by the one-dimensional movement of liquid on the membrane, and achieving a single test for a sample to obtain a large number of test results for multiple indicators.
[0061] 2. The present invention utilizes the high immune element loading capacity of the membrane to greatly increase the concentration of the immune element during the detection process, shortening the reaction time while achieving the same sensitivity.
[0062] 3. The liquid-blocking sheet structure included in the structure of the present invention can keep the reaction liquid covering all the binding points in the chip at the same time, so that the enzyme-containing immune complexes can start the catalytic reaction at the same time, achieving the effect of simultaneous detection of multiple indicators.
[0063] 4. The present invention uses a sufficient amount of liquid-absorbing material to provide driving force, so that the liquid automatically flows through the chip reaction area, completes the immune reaction, and also completes the necessary cleaning and separation. This process is a spontaneous process and does not involve complex manual operations and the assistance of the liquid system of automated equipment.
[0064] 5. The present invention can be applied to the simultaneous determination of multiple substances in the fields of medicine, veterinary medicine, agriculture, animal husbandry, food safety, environmental monitoring, biosafety, etc., significantly improving the work efficiency in these fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0065] FIG1A is a schematic diagram of the three-dimensional structure of a testing device in a specific embodiment of the present invention.
[0066] FIG1B is a schematic diagram of the three-dimensional structure of a testing device in a specific embodiment of the present invention, wherein liquid is dripped onto the sample receiving end 202 .
[0067] FIG1C is a perspective schematic diagram of a combination of a porous film and a liquid-blocking element of a testing device in a specific embodiment of the present invention.
[0068] FIG2A is a schematic diagram of the three-dimensional structure of a testing device in another embodiment of the present invention.
[0069] FIG2B is a perspective schematic diagram of a combination of a porous film and a barrier fluid element in a specific embodiment of the present invention.
[0070] FIG3 is an exploded view of the three-dimensional structure of a specific embodiment of the present invention.
[0071] FIG4A is a perspective schematic diagram of the operation of a testing device in a specific embodiment of the present invention.
[0072] FIG4B is a schematic diagram of the operation of adding a reaction solution dropwise to a test area according to a specific embodiment of the present invention.
[0073] FIG4C is a schematic diagram showing a specific embodiment of the present invention in which a reaction solution is added dropwise to a test area and a color appears in the test area to indicate a test result.
[0074] FIG. 5A is a photographic example of a test area in which a plurality of test units are distributed in an array in accordance with a specific embodiment of the present invention.
[0075] FIG5B is an example of a photograph of test results in which a plurality of test units are distributed in an array in a test area in one embodiment of the present invention.
[0076] FIG6 is an exploded perspective view of the testing device in one embodiment of the present invention.
[0077] FIG7A-FIG7D are photos of test results at different sample dilution multiples in a specific embodiment of the present invention.
[0078] FIG8A is a photograph of a test result of generating a fluorescent signal in a specific embodiment of the present invention.
[0079] FIG9 is a graph showing the test results of a specific embodiment of the present invention, in which the reaction liquid is brought into contact with one end of the porous film that receives the liquid and then flows through the porous film (Method 1, using a two-sided immunoreaction chip element, where the two-sided type indicates that there are two liquid-blocking elements on the porous film, and the specific structure is shown in FIG3 ).
[0080] FIG10 is a diagram showing the result of a reaction test in a specific embodiment of the present invention, in which the reaction liquid is directly dripped onto the test area (Method 2, using a two-sided immunoreaction chip element, where the side shape indicates that there are two liquid-blocking elements on the porous film, and the specific structure is shown in FIG3 ).
[0081] FIG11 is a photograph showing the results of reactions (after 25 minutes) using different liquids in a specific embodiment of the present invention, in which the reaction liquid contacts the chip reaction area (using a two-sided immunoreaction chip element, as shown in FIG3 ).
[0082] FIG12 is a schematic diagram showing the final result of the contact between the reaction liquid and the chip reaction area in a specific embodiment of the present invention (using a two-sided immunoreaction chip element, FIG3 ) (results after 10 minutes).
[0083] FIG13 is a structural diagram of an assembled testing device for testing allergens according to another specific embodiment of the present invention (allergen test).
[0084] FIG14 is a solution tank composed of multiple cavities for containing liquids in one embodiment, which contains sample diluent, blocking solution, washing solution, and labeled solution.
[0085] Figure 15 is a schematic diagram of the specific operating steps (described in Example 5), wherein step A is to insert the wash end of the test card into solution tank No. 1 10 to contact the sample solution in No. 1, step B is to insert it into solution tank No. 2 20, C is to insert it into solution tank No. 3 30, D is to insert it into solution tank No. 4 40, E is to insert it into solution tank No. 5 50, F is to directly add the reaction solution to the test area, and then step G is to read the results on the test area and the total amount of IgE antibodies or whether they exist.
[0086] Figure 16A shows the test effect (false positive) when the sample application end is not in contact with the blocking solution. The top photo is the original photo, and the bottom photo is the corresponding magnified photo of the result. It can be clearly seen that a false positive occurred in the test unit, and color also appeared in the background, indicating that a blocking reagent may be necessary for allergen testing.
[0087] FIG16B is a diagram showing the test effect of allowing the sample application end to contact the blocking solution, with a clean background and a correct negative display.
[0088] Detailed description
[0089] The structures involved in the present invention or the technical terms used therein are further described below. If not otherwise specified, they are understood and interpreted according to the general terms commonly used in the art. The preferred embodiments of the present invention are further described in detail below in conjunction with the accompanying drawings. It should be noted that the following embodiments are intended to facilitate understanding of the present invention and do not have any limiting effect on it. All features disclosed in the embodiments of the present invention, or all steps in the disclosed methods or processes, except for mutually exclusive features and / or steps, can be combined in any manner.
[0090] Detection
[0091] "Assay" means to test or examine a substance or material for the presence or absence of a substance or material, such as, but not limited to, a chemical substance, an organic compound, an inorganic compound, a metabolite, a drug or drug metabolite, an organic tissue or its metabolite, a nucleic acid, a protein, or a polymer. Additionally, "assay" means to test for the amount of a substance or material. Furthermore, "assay" also includes immunoassays, chemical assays, and enzyme assays.
[0092] sample
[0093] The detection device of the present invention or the sample collected includes biological fluids (such as case fluids or clinical samples), such as liquid samples or solid samples. Liquid samples or liquid samples, or liquid samples or liquid samples, can be derived from solid or semi-solid samples, including excreta, biological tissues and food samples. Solid or semi-solid samples can be converted into liquid samples by any appropriate method, such as mixing, crushing, macerating, incubating, dissolving or utilizing enzymatic digestion of solid samples in a suitable solution (such as water, phosphate solution or other buffer solutions). "Biological samples" include those derived from animals, plants and food samples, such as urine, saliva, blood (whole blood, serum, plasma, etc.) and its components, cerebrospinal fluid, vaginal secretions, sperm, feces, sweat, secretions, tissues, organs, tumors, cultures of tissues and organs, cell cultures and media derived from humans or animals. Preferably, the biological sample is urine, and preferably, the biological sample is saliva. Food samples include food-processed substances, final products, meat, cheese, wine, milk and drinking water. Plant samples include any plant, plant tissue, plant cell culture, and medium. "Environmental samples" are derived from the environment (e.g., liquid samples from a lake or other body of water, sewage samples, soil samples, groundwater, seawater, and wastewater samples). Environmental samples may also include sewage or other wastewater. Solid samples include samples that are free of water or contain very little water, such as solid soil, plant or animal tissue, or pharmaceutical powders, such as powdered samples of drugs of abuse.
[0094] Utilize the detection device suitable for the present invention, can detect any analyte.Preferably utilize the present invention to detect the small molecules of drugs in saliva, urine, or powder sample, or the virus in blood sample, such as HIV, coronavirus etc.The sample here can be any form of sample form or type. If it is solid, it can be processed by the solution that dissolves the sample, or the sample that exists in the form of solution. If the sample itself is liquid, it can be directly tested. Of course, the liquid sample can be diluted, dissolved, and processed to form a solution containing the liquid sample, so as to carry out the test or assay of the device of the present invention.So, the meaning of liquid sample here includes the sample that is liquid in itself, or the liquid sample formed by dissolving the solid by solution, also includes the sample (liquid or solid) diluted by diluent to become liquid sample, also includes the sample being processed in the early stage to form liquid sample.In some, allowing the sample to be added to the diluent solution, and then allowing one end of the porous film to contact the sample also belongs to a specific embodiment of the present invention.
[0095] Downstream and upstream
[0096] Downstream or upstream is divided according to the direction of liquid flow, and generally the liquid flows from the upstream to the downstream area. The downstream area receives the liquid from the upstream area, and the liquid can also flow along the upstream area to the downstream area. Here it is generally divided according to the direction of liquid flow. For example, on some materials that use capillary force to promote the flow of liquid, the liquid can flow in the direction opposite to gravity due to gravity. At this time, the upstream and downstream are still divided according to the flow direction of the liquid. For example, in the detection device of the present invention, when one end of the porous film contacts the liquid, the liquid flows from one end of the porous film to the other end by capillary force, and passes through the test area on the porous film during the flow. If the liquid here is a liquid sample, the first receptor fixed on the test area will specifically bind to the analyte in the liquid sample (if present).
[0097] In some methods, after the liquid sample passes through the porous membrane and the porous membrane is wetted, if one end of the porous membrane is expected to contact another liquid, such as a washing liquid, a sealing liquid, or other liquid for testing, then it is necessary to rely on the water absorption area connected to the porous membrane to provide capillary force to allow the liquid to continue to flow on the porous membrane. At this time, the flow relies on the water absorption area, allowing different types of liquids to flow on the porous membrane multiple times, from one end of the porous membrane through the test area to the other end. The "multiple times" here can mean the flow of the same solution multiple times, or different solutions can be absorbed by the porous membrane and flow, which will be explained in detail below.
[0098] Gas connection or liquid connection
[0099] Gas connectivity or liquid connectivity means that liquid or gas can flow from one place to another, and the flow may pass through some physical structures to guide it. The so-called passing through physical structures generally refers to the liquid passing through the surface of these physical structures, or the internal space of these structures to passively or actively flow to another place. Passive flow is generally caused by external forces, such as flow under capillary action. The flow here can also be the liquid or gas due to its own action (gravity or pressure), or it can be passive flow. The connectivity here does not necessarily mean that liquid or gas must exist. It only indicates the connection relationship or state between two objects in some cases. If there is liquid, it can flow from one object to another. This refers to the state of connection between two objects. On the contrary, if there is no liquid connectivity or gas connectivity between the two objects, the liquid cannot flow into or onto another object. Such a state is non-connected, a state of non-liquid or gas connectivity.
[0100] Analyte
[0101] Examples of analytes that can be used in the present invention include small molecules, including drugs (e.g., drugs of abuse). "Drugs of abuse" (DOA) refer to the use of drugs for non-medical purposes (usually to act as a narcotic). Abuse of these drugs can lead to physical and mental damage, dependence, addiction, and / or death. Examples of drugs of abuse include cocaine; amphetamines AMP (e.g., Black Beauty, White Amphetamine Pills, Dextroamphetamine, Dextroamphetamine Pills, Beans); methamphetamines MET (crank, methamphetamine, crystal, speed); barbiturates BAR (e.g., Valium, Roche Pharmaceuticals, Nutley, New Jersey); sedatives (i.e., sleep aids); lysergic acid diethylamide (LSD); depressants (downers, goofballs, barbs, blue devils, yellow jackets, methaqualone); tricyclic antidepressants (TCA, i.e. imipramine, amitriptyline and doxepin); dimethyldioxymethamphetamine (MDMA); phencyclidine (PCP); tetrahydrocannabinol (THC, pot, dope, hash, weed, etc.); opiates (i.e. morphine MOP or opium, cocaine COC; heroin, hydroxydihydrocodeine); antianxiety drugs and sedative hypnotics. Antianxiety drugs are a class of drugs mainly used to relieve anxiety, tension, fear, stabilize mood, and Drugs with hypnotic and sedative effects include benzodiazepines (BZO), atypical BZs, fused diazepam NB23Cs, benzodiazepines, BZ receptor ligands, open-ring BZs, diphenylmethane derivatives, piperazine carboxylates, piperidine carboxylates, quinazolinones, thiazine and thiazole derivatives, other heterocyclics, imidazole-type sedatives / analgesics (such as oxycodone OXY and methadone MTD), propylene glycol derivatives - carbamates, aliphatic compounds, anthracene derivatives, etc. The detection device of the present invention can also be used to detect drugs that are for medical purposes but are prone to overdose, such as tricyclic antidepressants (imipramine or analogs) and acetaminophen. After being absorbed by the human body, these drugs are metabolized into small molecules. These small molecules are present in body fluids such as blood, urine, saliva, sweat, or some body fluids.
[0102] For example, analytes detected by the present invention include, but are not limited to, creatinine, bilirubin, nitrite, protein (non-specific), hormones (e.g., human chorionic gonadotropin, progesterone, follicle-stimulating hormone, etc.), blood, white blood cells, sugars, heavy metals or toxins, bacterial substances (e.g., proteins or sugars specific to specific bacteria, such as Escherichia coli O157:H7, Staphylococcus, Salmonella, Clostridium, Campylobacter, L. monocytogenes, Vibrio, or Bacillus), and substances related to physiological characteristics in urine samples, such as pH and specific gravity. Any other clinical urine chemistry analysis can be performed using the lateral flow assay format in conjunction with the device of the present invention.
[0103] In some embodiments, the device of the present invention can detect at least two or more analytes at a time, for example, 5, 10, 15, 20, 30, 40, 50, 60, or 100 different analytes at a time. When high-throughput testing of multiple analytes is used, a plurality of test units can be set on the test area on the porous membrane, and these test units are arranged in an array. Each test unit can test one analyte. If there are 20-50 test units, 20-50 analytes can be tested at a time. In some embodiments, the analytes include tests for allergens, and 20-100 allergens can be tested. The following will be explained in detail.
[0104] The analyte here can also be in the sense of nucleic acid, such as nucleic acid fragments in a sample, or nucleic acid fragments after amplification, such as DNA, mRNA, or any other nucleic acid fragments, which can also be tested by the device of the present invention. Of course, it can also be an analyte in the sense of protein or polypeptide. For example, the device of the present invention can be used to test more than 20-200 different proteins or different polypeptide fragments in a sample at one time. Of course, it can also be different immune proteins in the sample. Of course, it can also be a substance that tests small chemical molecules in the sample, for example, 20-200 different small molecule compounds can be tested at one time. In some ways, the analyte of the present invention also includes the analyte after the sample has been processed, such as the nucleic acid fragment has been amplified, or the sample has been pre-treated by filtration, or the sample may contain a liquid sample after dilution.
[0105] Liquid flow
[0106] Liquid flow generally refers to the movement from one location to another. Generally, most natural liquid flows rely on gravity to flow from higher to lower locations. This flow also relies on an external force, meaning flow under external gravity, which can be considered natural gravity flow. In addition to gravity, liquid flow can also overcome gravity, moving from lower to higher locations. For example, this can occur through extraction, compression, or pressure, or from lower to higher locations due to pressure, or through overcoming the liquid's own gravity due to pressure. Of course, liquids can also flow from lower to higher locations based on capillary forces.
[0107] Porous film and water-absorbing area
[0108] In some embodiments, the porous film of the present invention is water-absorbent, meaning it can absorb water through the film's capillary action, allowing liquid to flow across the film. Any material that allows liquid to flow through capillary action can be used as the porous film of the present invention. The term "above" here primarily refers to allowing the liquid to pass through the porous film, as well as flowing across the surface of the porous film. In some embodiments, "above" refers to allowing the liquid to pass through the porous film while minimizing flow along the film's surface. Because porous films have thickness, liquids typically wet the entire film or pass through it. When the film contains a test area, primary receptors are affixed to the test area. These receptors are generally located not on the film's surface but within the film's pores, exposing sites on the receptors that specifically bind to the analyte. If the liquid flows only from the surface, the flow rate is too high, reducing the time the receptors have to bind to the analyte, resulting in incomplete binding and a false negative. However, allowing the liquid to pass through the film allows the liquid to fully wet the film, naturally slowing its flow and increasing its contact time with the primary receptors, allowing the sites to more fully bind to the analyte and increasing the accuracy of the test.
[0109] The so-called "water absorption" here refers to the ability of these materials to absorb water-based solutions and allow the liquid to flow through them, with the flow primarily driven by capillary forces. "Water" here can be any solution containing H2O molecules, such as purified water, water containing trace elements, or sterile water. It also includes liquid samples, biological samples, or solutions used to process solid samples using water as a solvent. The solution or liquid here also includes one or more of the following: liquid sample, eluent, blocking solution, reaction solution, wash or elution solution, as well as any other solution containing any other test components, such as a second receptor containing a labeled substance.
[0110] The term "porous" here has a broad meaning, and may refer to certain materials having multiple micropores, or to filter paper having micropores or capillary fibers, or to some materials having micropores formed by any process (such as engraving, printing, and other laser technologies), but these micropores are distributed on a substrate that is absorbent and allows liquid to flow on the substrate by capillary action. These can all be used as a specific embodiment of the porous film defined in the present invention.
[0111] In some methods, the porous membrane is initially brought into contact with a liquid, such as a liquid sample. The liquid can flow over the porous membrane due to the capillary action of the porous membrane, thereby wetting or completely wetting the porous membrane. In the present invention, "contact" refers to allowing the porous membrane to meet the liquid, thereby allowing the liquid to flow over the porous membrane or allowing the liquid to cover the porous membrane. The contact method can be to allow the liquid to be dripped onto the porous membrane, to immerse one end of the porous membrane in the liquid, or to allow the liquid to be dripped directly onto the test area of the porous membrane, and to form a liquid surface of a certain height in the test area.
[0112] When the porous film moistened by the liquid is expected to continue to contact the liquid, so that the liquid can continue to flow on the film and flow through the test area to provide the necessary reagents or conditions for the test area to be analyzed, at this time, the wet film has basically no capillary force or has actually lost its capillary force. This requires relying on other measures with water absorption capacity to provide the power for the liquid to flow. Therefore. In some methods, a water absorption area is provided, which is connected to the porous film, and relies on the capillary force of the water absorption area itself to allow the liquid to continue to move or flow on the wet porous film. In some methods, the water absorption area has a water absorption material, and the ability of the material to absorb liquid is much greater than the ability of the porous film to absorb liquid, or the volume of the saturated liquid absorbed by the water absorption material of the water absorption area is greater than or much greater than the volume of the saturated liquid absorbed by the porous film. In this way, even after the porous film is wetted and loses its capillary force, it can still allow liquid to flow through the porous film. This is because the water-absorbing area has a larger or more capillary force or a larger saturated liquid absorption capacity. Here, "saturation" refers to the maximum volume of water that the material with capillary water absorption capacity can absorb after losing its capillary force, or it can also be the maximum water absorption capacity or maximum water storage capacity of the material with capillary water absorption capacity. For example, the volume of the porous film wetted by liquid and losing its capillary force is 1 ml, and the volume of the water-absorbing material in the water-absorbing area that loses its capillary force or is saturated with liquid is 2 ml, 10 ml, 20 ml, 50, 100, or 200, 500 ml. In this way, when 1 ml of liquid is applied to the porous film, the 1 ml of liquid can be wetted by the capillary action of the porous film itself. If the wet porous film is to continue to absorb liquid and allow the liquid to flow on the porous film, it is necessary to rely on the water-absorbing material in the water-absorbing area to provide power so that the liquid can continue to flow on the film. Also can be understood like this, if wish to have 10 milliliters of liquid to flow through porous film for many times like this, then the saturated absorption capacity of the water-absorbing material in water-absorbing zone is 10 milliliters or greater than 10 milliliters at least, for example, between 12-50 milliliter.Here so-called " saturated absorption liquid " refers to the ability of the maximum absorption liquid that certain material relies on capillary force, thereby forfeits the total amount of the liquid that continues to absorb liquid till.Can be understood that, because the saturated absorption capacity of the absorption liquid in water-absorbing zone is greater than or far greater than the water-absorbing capacity of porous film, like this, when water-absorbing zone was connected with porous film, form an absorption or capillary force difference, like this, even if porous film has lost the ability that continues to absorb water after wetting, but can still rely on the capillary force of the water-absorbing material that is connected with porous film, can continue to allow porous film absorb more liquid, thereby allow liquid by the porous film after wetting.In some embodiments, the porous film is generally thin and has a uniform distribution of micropores relative to the absorbent material in the water-absorbing region, while the absorbent material can be thicker, such as filter paper or fiber, and have a larger volume of saturated liquid absorbed, thereby achieving the functions of the present invention. Therefore, in some embodiments, the thickness and volume of the absorbent material are greater than those of the porous film.
[0113] In some methods, in addition to being able to absorb liquid or allow liquid to pass through the porous film, a test area needs to be arranged on the porous film. Therefore, the test area is a place used to test the presence or quantity of the analyzed substance in the sample. In order to complete the function of the test area, some substances need to be processed on the test area. In some methods, the test area contains first receptors, which do not flow with the flow of liquid and are fixed on the porous film. In some methods, the test area includes multiple test units, each test unit is fixed with a first receptor, for example, the first receptor fixed by each test unit can specifically directly or indirectly bind to an analyzed substance in the sample to form a complex, so that multiple analyzed substances can be tested at one time, and the sample is the same sample. In some embodiments, the test area includes 10-100 test units, each test unit corresponds to an analyte in the sample, and a substance that can specifically bind to an analyte in the sample is fixed on each test unit. Then, 10-100 different first receptors are fixed on the 10-100 test units, so that 10-100 different analytes in the sample can be tested. In this way, the test area where multiple test units are arranged forms an array-like form.
[0114] In some embodiments, the porous film can be selected from nitrocellulose membrane, nylon membrane, or a non-absorbent material with capillary microchannels. In some embodiments, the porous film includes nitrocellulose membrane, polyvinylidene fluoride membrane, modified nylon membrane, or polyethersulfone membrane. The capillary channels formed by a process on the non-absorbent material here can also be fixed on its surface for specific binding (direct or indirect binding) to the analyte in the sample, which is also a specific embodiment of the porous film. Although non-absorbent materials such as plastic, glass, and ceramics do not absorb water themselves, they have capillaries on these materials. Liquids can flow through these capillaries, and the capillary force of the absorbent material can allow the liquid to flow on it multiple times.
[0115] In some embodiments, when the test area is located on a porous membrane, a test result control area may also be located on the porous membrane, and the test result control area is mainly an area for testing whether the test device is effective or whether the test result is effective. The test result control area may also include a plurality of test control units, which may be arranged around the test area. In some embodiments, if the test units of the test area are distributed in the test area in the form of an array, the test result control area may also be distributed in the form of an array around the test area, for example, distributed downstream of the test area, or distributed to the left, right or upstream of the test area.
[0116] In some embodiments, a porous film is provided with a test area and a test result control area. One end of the porous film can be used to contact the liquid, while the other end is connected to the water absorption area. For example, absorbent paper in the water absorption area is overlapped with the other end of the porous film. In this way, a test area and a test result control area can be distributed simultaneously on a porous film made of the same material. At the same time, the porous film serves as the liquid contact area upstream of the test area, and is connected to the water absorption area downstream of the test area. This method simplifies the production process. Of course, in some embodiments, the porous film can be made of multiple films with different materials or pore sizes. For example, a test area is distributed on one film, and a second film is distributed downstream of the test area to set the test result control area. A third film is set upstream of the test area as the liquid contact area, with the first, second, and third films stacked on top of each other. Although this method is complex, it is still a feasible method. In addition to the above method, other porous flow-guiding elements can be connected to one end of the porous film used for contacting the liquid. These flow-guiding elements are also porous materials. These porous materials can be filter paper, glass fiber, etc. to guide the liquid flow to the porous film.
[0117] In some embodiments, a test device, such as that shown in Figures 1A-3B, includes a porous membrane 200 and a water-absorbing region in fluid communication with the porous membrane. The porous membrane 200 can be disposed on a hard liner or base plate, with a test region 2001 disposed on the porous membrane. The porous membrane is made of the same material, but is divided into regions to perform different functions. The porous membrane is a single, integral membrane with a test region disposed in the center. One end of the membrane is configured to contact a liquid 202, while the other end contacts the water-absorbing region 201, with the center portion serving as the test region 2001. Upstream of the test region is a liquid-contacting region 202, also referred to as a sample application region. This region is designed to contact different types of liquids, such as a liquid sample, a cleaning solution, a blocking solution, a liquid containing a second receptor of a labeled substance, or one or more cleaning solutions, or a reaction solution that reacts with the labeled substance to generate a signal. Each contact with each liquid is separated by a predetermined time interval, such as 1-5 minutes. Alternatively, contact with one liquid may be followed by a 1-5 minute wait before contacting another liquid. After contacting the liquid, the capillary force of the porous film 200 itself allows the liquid to flow on the porous film, pass through the test area 2001, and then flow to the downstream water absorption area 100. At this time, it partially relies on the capillary force of the porous film itself and the capillary force of the water absorption area. After the porous film 200 is wetted by the liquid, if it is still necessary to allow the liquid-receiving area 202 to contact another liquid, it is hoped that the other liquid will continue to flow on the porous film. At this time, it mainly relies on the capillary force of the water absorption area to allow the liquid to flow from the contact area 202 to the test area, and then flow to the downstream 201 of the test area, and then flow to the water absorption area 100. The other end 201 of the porous film is contacted, covered, or superimposed by the water absorption material of the water absorption area. During the flow process, the liquid will pass through the test area 2001 and contact the test unit in the test area, thereby generating a binding reaction or chemical reaction, thereby testing the presence or specific amount of the analyte in the sample.
[0118] In some embodiments, a first liquid-blocking element 203 is provided on a porous film. The liquid-blocking element covers a porous region 202 divided into a contact liquid region on the porous film. The region is a region (such as FIG1B ) for contacting liquid 700. As shown in FIG2A , the porous film contains a sealed liquid-blocking element, a similar liquid reservoir 2061 is formed on the porous film, and then the liquid-blocking element 2062 at one end of the porous film forms a region 202 on the porous film to contact liquid. As shown in FIG4 C , FIG5A-5B , the porous film includes a plurality of test cells, and each test cell tests a kind of analyte. As shown in FIG5A , test area 2001 has 9 rows of test cells, and each row of test cells has 10-11 independent test cells 2052,2055, and there is a certain distance between each test cell. These places that do not contain test cells can be called interval areas or blank areas 2052, or there is a blank area between each test cell. Liquid flows downstream from contact area 202 in the direction of the arrow, passing through the test area, and then flows to the downstream 201 of the test area, where it is absorbed by the downstream water absorption area 100. These blank areas or spacing areas, or test cells, are primarily used to block the blocking reagent during subsequent operations to prevent false positives, as will be explained in detail later. Specifically, liquid enters at the lower end of Figure 6A, flows sequentially through the first row of test cells 2053, then through the second row, and finally to the last row of test cells 2051.
[0119] Test Area
[0120] In some embodiments, a porous membrane includes a test area. This test area is used to test or assay an analyte in a sample. A test substance is treated in this area. This test substance can directly or indirectly bind or react with the analyte in the sample to determine the presence or quantity of the analyte in the sample. In some embodiments, the test area includes one or more test units, each of which can test a specific analyte in the sample. If multiple test units are included, multiple analytes can be tested simultaneously in the same sample. In some embodiments, each test unit can be immobilized with a first receptor, each of which can directly or indirectly bind to a specific analyte in the sample. In some embodiments, the first receptor is an antibody or antibody fragment; or an antigen or antigen fragment. These first receptors can specifically bind to the analyte in the sample. If it is desired to test multiple analytes in a sample simultaneously, these different first receptors can be arranged in an array on the test area, or multiple test units can be arranged in an array on the test area (as shown in Figures 4, 5A-5B). This array is arranged in rows or columns on the test area, with each row or column containing multiple test cells, for example, 2-20 test cells. If there are 10-12 rows, with 2-20 test cells per row, there are a total of 20-240 test cells. These test cells are spaced apart, and each test cell can test a single analyte in the sample. This allows for simultaneous testing of 20-240 analytes in the sample, enabling high-throughput testing, as shown in Figures 5A-5B. These first receptors are fixed to the test cells. For example, if each test cell is fixed with a single first receptor, then if there are 100 test cells, 100 different first receptors are fixed. When a liquid sample flows from an upstream position 5023 to a downstream position 2051 of the array, each test cell comes into contact with the liquid sample, reacting or binding to form different complexes. For example, if the liquid sample contains the target analyte, the first receptors capture the target analyte, forming complexes. These complexes are also unable to flow with the liquid. For example, in FIG5A-5B , FIG5A shows nine rows of test cells arranged therein, wherein the downstream row of test cells serves as a test structure control array, the leftmost row 2057 also serves as a test result control array cell, and the center row is a test cell array 2054. When a test is performed, if the sample contains the analyte to be tested, the test cells in the test array will generate a test signal, as shown in FIG5B . Color appears on test cells 2060, 2059, and 2058 in the test area, indicating a positive result, while arrays 2056 and 2057 in the test result control area all display positive results, indicating that the test results of the test cells are valid.During the production process, a microneedle is first used to drop the first receptor on the test area of the porous film, so that the first receptor is fixed on the porous film, and then dried. When there are multiple items to be tested, multiple microneedles can be used to deliver them to the porous film at the same time to form an array of test areas.
[0121] The use of a test unit to test the analyte in a sample can be performed based on the principle of immune binding, or it can be implemented in the form of a non-immune principle, such as the principle of nucleic acid binding. For example, a sequence complementary to the target nucleic acid can be fixed on the test unit. After the target nucleic acid is amplified, the target nucleic acid can be combined with the fixed complementary nucleic acid, and then a labeled probe is added. The probe is then also combined with the target nucleic acid, thereby achieving the test of nucleic acids of different targets. In some embodiments, the method using the nucleic acid principle includes, but is not limited to, a DNA mixture solution of the same sequence or complementary sequence after PCR amplification for measuring DNA, and a DNA mixture solution of the same sequence or complementary sequence after inverse PCR amplification for measuring RNA. Further, the above-mentioned immunoreaction chip element can be applied to nucleic acid hybridization experiments, and the intermediate complex formed is a porous film-DNA (fixed on the film)-DNA (target nucleic acid)-DNA (probe)-FITC complex, DNA-DNA-Biotin complex, DNA-DNA-Bition-streptavidin-enzyme complex, DNA-DNA-FITC-Anti-FITC antibody-enzyme.
[0122] Generally, the easiest method to implement is based on the principle of immune binding. Common methods include one-step sandwich, two-step sandwich, indirect, and competitive methods. In some methods, the immune method generally involves fixing a first receptor on the test unit. This receptor can then specifically bind to the analyte, or the first receptor can specifically bind to the complex substance, or of course, it can also specifically bind to the analyte, so that the first receptor captures the complex or analyte. The analyte is then allowed to specifically bind to a second receptor carrying a labeled substance, which can also specifically bind to the analyte. In this way, the second receptor carrying the labeled substance is captured, and by reading the quantity or presence of the labeled substance, the presence or quantity of the analyte can be obtained. In some methods, this complex can be some intermediate after the reaction, such as a protein-protein complex, a protein-protein-labeled protein complex, or a protein-labeled protein complex. Protein here also refers to a polypeptide fragment. The labeled protein can be an enzyme or a luminescent protein. In some methods, the presence or absence of a marker protein in the complex is used as the basis for classification. When the immune complex formed does not contain a marker protein, all liquids or liquid reagents contact the liquid inlet area of each test unit in the test area and flow unidirectionally through the micropores on the porous membrane through the test area, out of the drainage area and absorbed and stored by the absorbing material. When a complex with a marker protein is formed, the reaction liquid is directly added to the test area on the porous membrane, and the added reaction liquid is slowly absorbed and stored by the absorbing material through the drainage area. In this way, the reaction liquid contains a reagent that reacts with the marker substance, so that after the reaction, a substance is generated that indicates the presence or amount of the analyte. The substance can be a color substance visible to the naked eye, or a non-color substance that can be read by a machine, but a luminescent substance, such as a fluorescent substance, or other substances that are visible or invisible to the naked eye.
[0123] In some embodiments, the first receptor and the second receptor can be antibodies or antibody fragments. The first receptor is fixed on the test area. If there are multiple different first receptors, they are fixed in an array. The second receptor is accompanied by a labeling substance. The labeling substance here is any substance that can directly or indirectly indicate the presence or quantity of the analyte, such as fluorescence, colored particles, and colored dyes. Alternatively, the labeling substance reacts with the reaction liquid to generate some reaction products that can indicate the amount or existence of the analyte. These reaction products can be colored substances, luminescent substances, or any other substances. In some embodiments, the labeling substance is an enzyme, and the reaction liquid contains a substance that reacts with the enzyme to generate a colored substance. The colored substance is precipitated on the test area or the test unit, thereby indicating the presence or amount of the analyte. If the reaction product emits light, the amount of the analyte present can be judged based on the intensity of the light.
[0124] In some embodiments, when multiple test units 2060, 2059, and 2058 are provided on the test area, each test unit may correspond to an analyte in a specific test sample. However, this is often insufficient for comprehensive testing. Therefore, a reference test unit may be provided on the test area. This reference test unit is specific to a receptor other than the multiple analytes. If multiple test units can detect the analyte, or some test units can detect the analyte, the reference test unit may still be positive. If all test units are negative, a positive result from the reference test unit indicates the presence of the analyte, which cannot be detected by the other multiple test units. For example, when testing for anti-allergic antibodies, even if there are many anti-allergic proteins or antibodies, sometimes multiple test units may all be negative, but the reference test unit may be positive. This at least indicates that the anti-allergic antibodies are present in the sample, but are not specifically tested by the specific test unit. Of course, the reference test unit 2017 can also be used as a test for the total amount of similar analytes. For example, when testing anti-allergic antibodies, multiple test units correspond to specific anti-allergenic antibodies, and the reference test unit is used to test the total anti-allergenic antibodies. This is also possible.
[0125] First receptor and second receptor
[0126] In some embodiments, the test area is fixed with one or more first receptors, which can directly or indirectly bind to the analyte in the sample. The first receptor here can be an antibody, an antibody fragment, an antigen or an antigen fragment, a nucleic acid or a nucleic acid fragment, or a polypeptide fragment. The second receptor can also specifically bind to the analyte, and this binding can be direct or indirect. The second receptor here can also be an antibody, an antibody fragment, an antigen or an antigen fragment, a nucleic acid or a nucleic acid fragment, or a polypeptide fragment. In some embodiments, the second receptor carries a marker substance, and these marker substances can be directly or indirectly connected or coupled to the second receptor. For example, when detecting antibodies in the sample (analyte), the first receptor can be an antigen, and the second receptor can be an antibody against the antibody in the sample. In some embodiments, the first receptor can be a first antibody against the antibody in the sample, and the second receptor can be a second antibody against the antibody in the sample. When the analyte in the test sample is an antigen, the first receptor can be a first antibody against the antigen, and the second receptor can be a second antibody against the antigen. These second antibodies can also be connected to a marker, and the marker acts as a signal substance to show the presence or quantity of the analyte in the sample.
[0127] Antibody
[0128] The antibody used in the present invention can be any antibody that is capable of specifically binding to the analyte in the sample. The antibody that can be used as a binding agent can be any antibody known to those skilled in the art. "Antibodies" can be immunoglobulin molecules and antigen-binding portions of immunoglobulin molecules, i.e., molecules containing an antigen-binding site that specifically binds to an analyte, analyte analog, or ligand ("immunoreaction"). This term also includes derivatives of antibodies that retain binding ability, as well as any protein containing a binding domain that is homologous or largely homologous to the binding domain of an immunoglobulin. These proteins may be derived from natural substances or may be partially or completely synthesized. An antibody may be monoclonal or polyclonal. An antibody may be a member of any immunoglobulin class, including any human immunoglobulin class: IgG, IgM, IgA, IgD, IgG, and IgE. An "antibody fragment" is a derivative of an antibody or a portion of an antibody that is less than full-length. An antibody fragment can retain at least one significant site of binding ability of a full-length antibody. Examples of antibody fragments include, but are not limited to, Fab, Fab', F(ab')2, scFv, Fv, dsFv dimer, and Fd fragments. Antibody fragments can be produced in any manner. For example, antibody fragments can be produced by enzymatic or chemical cleavage of an intact antibody, or by recombination from a gene encoding a partial antibody sequence. In other words, antibody fragments can be partially or completely recombinantly produced. Antibody fragments can be any single-chain antibody fragment. In other words, an antibody fragment can contain multiple peptide chains linked to each other, for example, by disulfide bonds. Antibody fragments can also be any multimolecular complex. A functional antibody fragment typically contains at least about 50 amino acids, while more antibody fragments typically contain at least about 200 amino acids. Single-chain Fvs (scFvs) are recombinant antibody fragments that consist only of a variable light chain (V L ) and variable heavy chain (V H ) are covalently bound to each other via polypeptide chains. L and V H One of the two variable domains has an amino-terminal region. The polypeptide chain length and composition are variable, and the length can bridge the two variable domains without significantly affecting the atomic arrangement. The polypeptide chain is typically composed primarily of stretches of glycine and serine residues, with some glutamic acid and lysine residues interspersed to enhance solubility. "Dimer" refers to a dimer of a single-chain Fv. The monomers of the dimer typically contain shorter peptide chains than most single-chain Fvs, and they exhibit a propensity to form dimers.
[0129] The "Fv" segment consists of a V H and a V L The term "dsFv" herein refers to a fragment comprising a stable VH -V L Fv that eliminates the intermolecular disulfide bonds of the heavy chains. A "F(ab')" fragment is an antibody fragment that is essentially the same as the fragment obtained by digesting an immunoglobulin (usually IgG) with pepsin at pH 4.0-4.5. This fragment can also be recombinantly synthesized. A "Fab'" fragment is an antibody fragment that is essentially the same as the fragment obtained by reducing the disulfide bonds connecting the two heavy chains of the F(ab') fragment. A Fab' fragment can also be recombinantly synthesized. A "Fab" fragment is an antibody fragment that is essentially the same as the fragment obtained by digesting an immunoglobulin (usually IgG) with papain. A Fab fragment can also be recombinantly synthesized. The heavy chain fragment on the Fab fragment is the Fd fragment.
[0130] The antibodies here can also be any kind of antibodies in the analyte, and these antibodies can also be used as the analyte.
[0131] Nucleic Acids
[0132] In some ways, the device of the present invention can be used to test the number or existence of nucleic acids in a sample in a high-throughput manner. Generally, the first receptor is a sequence that is essentially complementary to the target nucleic acid, and these sequences are fixed on the test area. The target nucleic acid or target nucleic acid (also referred to as the analyte) is present in the sample, or the target nucleic acid or target nucleic acid in the sample is a product of amplification. The complementary sequence is allowed to bind to the target nucleic acid or the amplified nucleic acid to form a complex, and then the probe is allowed to bind to the target nucleic acid or target nucleic acid. The probe can carry a marker, such as a fluorescent marker, so that the amount of fluorescence on the probe can be used to confirm the amount of target nucleic acid. The amplification here can be any type of amplification, such as PCR amplification, isothermal amplification, RPA or RAA technology. Nucleic acid amplification requires primers and reagents necessary to complete the amplification. These methods are all traditional technologies.
[0133] The term "substantially complementary" when used to define amino acid or nucleic acid sequences means a specific target sequence, such as an oligonucleotide sequence, which is substantially complementary to all or part of a selected sequence, and which will therefore specifically bind to a portion of the mRNA encoding the selected sequence. Therefore, typically the sequence will be highly complementary to an mRNA "target" sequence, and will have no more than about 1, about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, or about 10 base mispairings in the complementary portion of the sequence. In many cases, it may be desirable that the sequence be an exact match, i.e., fully complementary to the sequence specifically bound to the oligonucleotide, thereby having zero mispairing along the complementary strand. Thus, highly complementary sequences will typically be quite specifically bound to the target sequence region of the mRNA, which will effectively reduce and / or even inhibit the translation of the target mRNA sequence into a polypeptide product.
[0134] A substantially complementary nucleic acid sequence will be greater than about 80% complementary to a corresponding nucleic acid target sequence that specifically binds to the nucleic acid (or "% exact match"), and will more preferably be greater than about 85% complementary to a corresponding target sequence that specifically binds to the nucleic acid. In certain aspects, as described above, it will be desirable to have even more substantially complementary nucleic acid sequences for use in the practice of the present invention, and in such cases, the nucleic acid sequence will be greater than about 90% complementary to a corresponding target sequence that specifically binds to the nucleic acid, and in certain embodiments may be greater than about 95% complementary to a corresponding target sequence that specifically binds to the nucleic acid, and even up to and including about 96%, about 97%, about 98%, about 99%, and even about 100% exact match complementary to all or a portion of the target sequence that the designed nucleic acid specifically binds to.
[0135] The percent similarity or percent complementarity of any disclosed nucleic acid sequence can be determined, for example, by comparing sequence information using the GAP computer program, version 6.0, available from the University of Wisconsin Genetics Computer Group (UWGCG). The GAP program utilizes the alignment method of Needleman and Wunsch (1970). Briefly, the GAP program defines similarity as the number of aligned symbols (i.e., nucleotides or amino acids) that are similar divided by the total number of symbols in the shorter of the two sequences. Preferred default parameters for the GAP program include: (1) a unary comparison matrix for nucleotides (containing a value of 1 for identity and a value of 0 for non-identity), and the weighted comparison matrix of Gribskov and Burgess (1986), 2) a penalty of 3.0 for each gap and an additional penalty of 0.10 for each symbol in each gap; and (3) no penalty for end gaps.
[0136] Naturally, the present invention also includes nucleic acid segments that are complementary, essentially complementary, and / or substantially complementary to at least one or more of the specific nucleotide sequences specifically described herein. A "complementary" nucleic acid sequence is a nucleic acid sequence that is capable of base pairing according to the standard Watson-Crick complementarity rules. As used herein, the term "complementary sequence" refers to a substantially complementary nucleic acid sequence, which can be assessed by comparing identical nucleotides as described above, or defined as being capable of hybridizing to one or more of the specific nucleic acid segments disclosed herein under relatively stringent conditions, such as those described immediately above.
[0137] As used herein, the terms "substantially free" or "essentially free" with respect to the amount of a component preferably mean that the composition contains less than about 10%, preferably less than about 5%, and more preferably less than about 1% by weight of a particular compound. In preferred embodiments, these terms refer to less than about 0.5%, less than about 0.1%, or less than about 0.01% by weight.
[0138] The probes and primers used in the present invention can have any suitable length. By assigning numerical values to the sequence, for example, the first residue is 1, the second residue is 2, etc., an algorithm can be proposed to limit all probes or primers contained in a given sequence: n to n+y, where n is an integer from 1 to the last number of the sequence, y is the length of the probe or primer minus 1, and where n+y does not exceed the last number of the sequence. Thus, for a probe or primer of 25 base pairs (i.e., a "25-mer"), the set of probes or primers corresponds to bases 1 to 25, bases 2 to 26, bases 3 to 27, bases 4 to 28, etc., over the entire length of the sequence. Similarly, for a probe or primer of 35 base pairs (i.e., a "35-mer"), exemplary primer or probe sequences include, but are not limited to, sequences corresponding to bases 1 to 35, bases 2 to 36, bases 3 to 37, bases 4 to 38, etc., over the entire length of the sequence. Likewise, for a 40-mer, such a probe or primer would correspond to nucleotides from the first base pair to bp 40, from the second bp of the sequence to bp 41, from the third bp to bp 42, and so on, while for a 50-mer, such a probe or primer would correspond to a nucleotide sequence extending from bp 1 to bp 50, from bp 2 to bp 51, from bp 3 to bp 52, from bp 4 to bp 53, and so on.
[0139] The terms "substantially correspond to," "substantially homologous," or "substantial identity," as used herein, refer to a characteristic of a nucleic acid or amino acid sequence wherein a selected nucleic acid or amino acid sequence has at least about 70 or about 75% sequence identity compared to a selected reference nucleic acid or amino acid sequence. More typically, the selected sequence and the reference sequence will have at least about 76, 77, 78, 79, 80, 81, 82, 83, 84, or even 85% sequence identity, more preferably at least about 86, 87, 88, 89, 90, 91, 92, 93, 94, or 95% sequence identity. Still more preferably, highly homologous sequences often share greater than at least about 96, 97, 98, or 99% sequence identity between the selected sequence and the reference sequence to which it is compared.
[0140] Array
[0141] In some embodiments, the test area includes multiple test units or multiple different first receptors arranged in a row. These receptors can specifically bind to a complex substance or an analyte, which can then specifically bind to a second receptor. In some embodiments, the second receptor can carry a labeled substance. In some embodiments, multiple test units or multiple first receptors are arranged in rows on the test area. For example, the test area is arranged in a region of a porous membrane, and the test units within the test area are arranged in an array. The "array" herein includes multiple test units arranged in a square matrix, including a single row, a single column, multiple rows, or multiple columns. Alternatively, rows and columns can be arranged in a staggered arrangement. In some embodiments, each test unit is spaced a certain distance apart, or each test unit is spaced a certain distance apart from surrounding test units, or each test unit is spaced a certain distance apart or spaced apart. Generally speaking, the array can be any shape, such as a square, rectangle, triangle, trapezoid, or rhombus. Of course, a single test unit that tests only one analyte in a sample is also a special form of a row. Therefore, by arranging them in an array in a test area, one or more analytes in a sample can be detected, for example, 2-200, 2-100, 2-50, or 2-40 analytes. These analytes can be tested simultaneously using the same sample.
[0142] In some embodiments, the test cells or first receptors are arranged in an array on the test area. This allows liquid to flow through each test cell, allowing the first receptors to directly contact the liquid sample. If an analyte is present, the analyte can bind directly or indirectly to the first receptors. Therefore, the test area is located in the direction of liquid flow.
[0143] How to arrange the first receptors in an array on the test area? Microneedles can be used to drop multiple different first receptors onto the test area at once, allowing them to be fixed on the test area and then allowed to dry or bake. Of course, the first receptor solution can also include any other components that help the first receptors be fixed to the test area without substantial movement. A plurality of microneedle arrays can be used, with each microneedle connected to a receptor solution. Droplets are generated from the microneedle outlets and applied to the porous film using a pump, thereby forming a plurality of test units on the porous film at once.
[0144] Liquid or solution
[0145] Liquid is a general term for liquids required to complete the test of the substance being analyzed. Liquids can take many different forms or have different functions. These are required to complete the test. Of course, they are not necessarily required. However, they are preferred implementation methods to obtain better test results.
[0146] In some embodiments, the liquid of the present invention includes a liquid sample. A solid sample dissolved into a solution is also a specific embodiment of a liquid sample of the present invention. For example, a solid sample needs to be dissolved and diluted using a liquid solvent to become a liquid form, generally a liquid solvent containing water for dissolution or dilution. Of course, the sample itself is liquid, and it is also possible to allow one end of the porous membrane to directly contact the liquid sample, which is also a specific embodiment of the present invention. In some embodiments, even if the sample itself is a liquid sample, it is always desirable to treat the liquid sample, such as using a diluent solution to treat the liquid sample, or allowing the liquid sample to undergo pre-treatment, such as filtration, purification, centrifugation, etc., and then dilute the sample with a diluent solution. After dilution, the treated liquid sample is then allowed to contact one end of the porous membrane and allowed to flow on the porous membrane, thereby passing through the test area, the test result control area, and then flowing to the water absorption area. Alternatively, when the required sample is very small, or when it may contain a high level of the analyte, in order to complete the wetting of the porous membrane test area, the small amount of sample can be diluted with a solution to increase the volume of the liquid sample, allowing the liquid to wet the test area.
[0147] Typically, during the first test, a sample solution or a solution containing a sample is first brought into contact with one end of the porous membrane, which is then allowed to flow through the test area, thereby allowing a first receptor or multiple different first receptors to contact the liquid sample, such as a first antibody. If analytes are present in the liquid sample, the multiple first receptors bind to the multiple analytes in the liquid sample, forming binding complexes that are then immobilized on the multiple test units. At this point, the dry porous membrane is wetted. If excess liquid flows through the test area, the excess liquid sample will flow into the water absorption area after wetting the entire membrane and be absorbed by the absorbent material in the water absorption area.
[0148] If you want to increase the accuracy of the test, after the porous film absorbs the liquid sample, you want to use a cleaning solution to clean the wet film to wash away other substances that are not bound by the first receptor, such as non-target substances. When the substance being analyzed is an antibody, you can wash away some impurities, such as non-antibodies, such as red blood cells and other impurities in a blood sample. The components of the cleaning solution can be some buffer reagents. The main function of these cleaning solutions here is to rinse away impurities or interfering substances on the porous film in order to enhance the reaction effect of the next reaction. For example, after one end of the porous film receives the liquid sample, the cleaning solution is used to clean the test area to wash away impurities or interfering substances. After cleaning, the end of the porous film that contacts the liquid is contacted with a solution containing a labeled substance. The second receptor is labeled and can be captured by the complex when it flows to the test area. The marker will be fixed on the test unit. The purpose of using the cleaning solution at this time can be to wash away the second receptors that are not captured by the complex to avoid the generation of positive results later. If the marker itself has a color signal, it is also necessary to clean it. If you want to test 10 or dozens of analytes in a very small test area, the distance between each test unit is relatively close. After the marker with the color particle signal is fixed by the test unit, a cleaning solution is used to rinse off the excess markers that are not fixed by the test unit, so that the test on the test unit is more accurate. In the prior art, especially when the concentration in the sample is very low, or near the test threshold (such as below the threshold, or slightly above the threshold), it is more important to obtain an accurate test at this time. If the color particles that are not fixed are not rinsed off, false positive or false negative results may be caused. However, the use of a cleaning solution can remove the excess free markers that are not fixed by the test unit, making the results more accurate. In addition, the boundaries between the test units can also be made clearer, and when reading with the naked eye or a machine, the readings are clearer and more accurate. It can be understood that the type of cleaning reagent here can be freely selected according to the specific product, and the timing or conditions for contacting one end of the porous film with the cleaning solution can also be freely selected according to the specific product.
[0149] In some methods, a wet porous film can be brought into contact with a solution containing a blocking reagent, and the solution can be allowed to flow through the test area. The blocking reagent is used to block the micropores in other areas of the porous film that do not contain the first receptor. The other areas here can be called blank areas. The blank areas are the pores between the test units, or between the test control area or the test reference unit, to prevent the subsequently added reagents from being adsorbed or fixed by the micropores of the porous film in the blank areas, causing background interference, or the blocking reagent is used to block the non-specific sites on the test unit, and then increase the specificity of binding when the second receptor flows through the test area. Therefore, the blocking reagent can be a reagent of any composition, any reagent that can block, occupy, fill the micropores in other blank areas of the porous film where the first receptor is not fixed, or replace the reagent that blocks the non-specific sites on the test unit. These blocking reagents are used to purify the test background in the subsequent test and reduce the impact of the background on the test results. Of course, if the test area also includes a test result control area or a test reference area, generally, the blocking reagent solution flows from one end of the porous film to the other end, substantially covering the test area, the test result control area, or one or more areas in the test reference area. In some embodiments, the blocking reagent includes a protein, a polypeptide, or other substances similar to proteins or polypeptides, so that these blocking reagents can play a blocking role, which is related to the size of the micropores on the porous film. As long as the size of the micropores on the porous film is determined, a protein of appropriate size can be selected to block these micropores. It can be understood that when the porous film needs to be pre-treated and fixed with the first receptor, these receptors have occupied one point or multiple micropores of the porous film, for example, multiple micropores are occupied or filled by the first receptor, and the blocking reagent is mainly used to block those micropores that are not occupied by the first receptor. These micropores are not selective for the adsorption of substances. If there is no selective adsorption of many irrelevant substances, it may cause the background to deepen in the later stage, and it is not possible to distinguish the signal on the test unit well. Of course, the blocking reagent is used to block some non-specific sites on the test unit, so that the substance that is subsequently bound to the test unit is more specific.
[0150] In some embodiments, the blocking reagent is primarily casein. It will be appreciated that these blocking reagents are not suitable for proteins, nucleic acids, or antibodies that have the same properties as the first receptor. In some embodiments, the blocking solution can be mixed with the wash solution to form a single solution. Alternatively, the wash solution can be present separately from the blocking solution.
[0151] The order in which the blocking solution, washing solution or cleaning solution, and the sample solution contact the porous membrane can be arbitrary, for example, the blocking solution is first contacted with the porous membrane, then the sample solution is contacted with the porous membrane, and then the cleaning solution is contacted with the porous membrane. Or after each contact with other solutions, the membrane is cleaned with the cleaning solution. In some methods, the porous membrane can be first contacted with the sample solution, and then the porous membrane is contacted with the blocking solution or a mixed solution of the blocking solution and the cleaning solution. This method is one of the preferred methods. In some methods, the solution used to dilute or dissolve the sample does not contain protein or blocking reagent.
[0152] In some approaches, after a blocking reagent or a solution containing a blocking solution contacts a porous membrane, the blocking solution flows through the membrane via capillary action in the water-absorbing regions, thereby sealing the micropores or nonspecific sites on the membrane. Once this is complete, a second receptor solution containing a labeled substance contacts the porous membrane. From the end of the porous membrane that contacts the liquid, the second receptor solution flows through the test region via capillary action in the water-absorbing regions, thereby specifically binding to the complex formed between the analyte and the first receptor. The second receptor contains a labeled substance that can generate a signal, such as an optical signal, or the labeled substance itself may generate a color signal, or the labeled substance may generate a signal in combination with the reaction solution. Therefore, in some approaches, the blocking solution contacts the porous membrane and flows through the test region before the second receptor solution contacts the porous membrane. This allows the second receptor to bind only to the analyte bound to the first receptor, while minimizing adsorption to the pores in the remaining, unoccupied areas. Of course, in some cases, a blocking solution is not necessary, nor is washing after contact with the sample. When the marker substance is a colored particle or water-soluble dye, the second receptor solution contacts the porous membrane and flows through the test area. The analyte captured by the first receptor in the test area captures the second receptor containing the labeled substance, thereby precipitating on the second receptor or being captured and fixed by the complex. Indirectly, the colored particles or dye also precipitate, indicating the presence or quantity of the analyte.
[0153] When the marker carried by the second receptor needs to react chemically with the reagent in the reaction solution to generate a signal, it is best to use a blocking reagent to block the porous film in advance, so that the second receptor can bind to the complex formed by the first receptor-analyte as much as possible, and try not to be adsorbed by the micropores in other blank areas. In this way, there are a few second receptors with markers in the blank area, and most of the second receptors with marker substances are bound by the complex on the test unit. When the reaction reagent in the reaction solution reacts with the marker, the signal is mainly concentrated in the area of the complex, while other blank areas rarely generate signals, reducing the interference of background signals, thereby making the test results more accurate. The blank area mentioned here refers to the area where no substance has been processed, including the area between test units, the area between the test structure control units in the test result control area, and the area between the test result reference area and the test unit. These blank areas generally do not contain receptors, but include multiple micropores.
[0154] To achieve detection, we use an enzyme labeling method, in which an enzyme is labeled on the second receptor. When the liquid containing the enzyme-labeled second receptor flows through the test area, the test reference area or the test result control area, the second receptor binds to the complex and is fixed on the test unit, or on the test result control unit, or on the test reference unit. The second receptor here can be as defined above, and can be an antibody, an antigen, a nucleic acid probe, etc. When the solution with the enzyme-labeled second receptor flows through the above areas, the excess liquid still relies on the capillary force of the water-absorbing area to allow the enzyme-labeled solution to flow through the porous film. The method is still that one end of the porous film contacts the liquid, allowing the liquid to pass through the above areas and flow to the water-absorbing area.
[0155] In some methods, a second receptor containing an enzyme label is immobilized in a corresponding area, and a cleaning solution can be used to clean the reaction area (which can be one or more of the test area, the test result control area, the test result reference area, etc.) to remove any residual enzyme-containing second receptor reagent. These cleaning solutions are a preferred solution, but are not required.
[0156] In some methods, after the second receptor containing the enzyme is bound or captured by the reagent in the reaction area, a substrate solution or reaction solution corresponding to the labeled enzyme is then added. The reaction solution contains a reagent that reacts with the enzyme, and the reaction reagent reacts with the enzyme to produce a signal. For example, if the reagent in the substrate solution or reaction solution comes into contact with the enzyme-labeled immune complex, it can be catalyzed by the enzyme to produce a signal, such as a substance visible under visible light or a fluorescent substance or a dim light substance, which can be observed with the naked eye or by measuring the fluorescence and dim light signals with a sensor.
[0157] Flow of solutions or liquids and porous membranes
[0158] In some embodiments, the above liquids, such as liquid samples, cleaning solutions, second receptor solutions containing markers, and other cleaning solutions, can be repeatedly contacted from one end of the membrane, relying on the capillary force of the water-absorbing area at the other end of the membrane to flow through the area on the membrane, thereby performing multiple different reactions and completing the test of the analyte. For example, the fixed first receptor binds to the analyte to form a complex, and then the second receptor containing the marker is captured by the complex and fixed on the membrane. When the marker needs to contact and react with the reaction solution, the reaction solution needs to flow through the membrane, allowing the reaction solution to react with the marker substance to generate a signal, such as a signal visible to the naked eye, such as a color signal, or a signal read by a device, such as a fluorescent signal, etc. The color signal here can be a color precipitate, a precipitate of a colored substance, or any other form of visible signal to the naked eye. The reaction liquid can also be absorbed into the porous membrane from the end of the porous membrane that contacts the sample, pass through the test area, complete the contact reaction with the marker, and finally flow into the water-absorbing area.
[0159] The above liquid flows are all from upstream to downstream, for example, from the end of the porous film that contacts the liquid (upstream, the end 202 that receives the liquid) to the test area 2001, and then flows to the test result control area, or the test reference area. The test units of these test areas are arranged in the form of an array on the porous film. The array close to the upstream always contacts the liquid first, and the array far away from the upstream contacts the liquid later, and the array far away from the water absorption area contacts the liquid later.
[0160] Different markers and analytes, as well as different first and second receptors, require the selection of specific micropores and thicknesses of the porous membrane to ensure that different types of liquids can flow through the membrane multiple times while completing the necessary reactions during the flow process. It is understood that some reactions may require longer times, while others may require shorter times. This can be effectively selected by utilizing the thickness of the porous membrane and / or the size of the micropores in specific experiments, which can be freely determined by those skilled in the art after reading the description of the present invention.
[0161] In some approaches, the appropriate porous membrane is selected based on the size of the analyte. For example, when the first receptor is fixed to the test area, if there are multiple first receptors, they are fixed in the test area in the form of an array. If the analytes in the liquid sample are of various types and relatively large molecular weight, and require a long time to contact and react with the first receptors, a membrane with a small pore size can be selected to slow the flow rate of the liquid sample through the membrane, allowing the first receptors to have sufficient time to contact the sample and fully capture the analytes in the sample.
[0162] In addition, in some other methods, if there are many analytes to be tested at one time, such as 20-50 analytes to be tested at one time, it is also hoped that the liquid flow rate will be slower, giving more than 20-50 test units a longer contact time with the liquid sample, so that each test unit can contact the liquid sample as much as possible, thereby fully capturing the analytes. At this time, the molecular weight of the analyte may be very small, or the spatial structure is very small, such as small chemical molecules. At this time, a porous film with a small pore size is selected to slow down the flow rate of the liquid and complete the reaction during the flow process.
[0163] In other ways, when the second receptor containing the marker is in the form of a liquid and is in contact with the porous film, the volume or molecular weight of the marker is also related to the pore size of the porous film. When the marker is in the form of particles, the size of the particles may generally be smaller than the size of the micropores or equivalent to the size of the micropores on the film, such as nano-scale particles, such as gold particles, latex particles. In this way, the second receptor containing the marker can flow through the test area when the analyte is relatively small. If it contains multiple test units (for example, 10, or more than 20), these nano-scale particles may block the micropores of the porous film here, resulting in the liquid being unable to effectively flow through each test unit, thereby affecting the accuracy of the test. At this time, it is necessary to select a porous film that is much larger than the size of the marker. In this way, the second receptor containing the particles can effectively capture the complex (first receptor-analyte) and precipitate when the liquid flows through the porous film.
[0164] When an enzyme is chosen as a marker, it is typically in the form of a protein, resulting in a relatively large molecular weight and particle size, but this is significantly smaller than the size of the porous membrane and will not clog the membrane's pores. If the enzyme is considered a sphere, the size of the labeled enzyme is related to its molecular weight. For example, horseradish peroxidase (HRP), with a molecular weight of approximately 40 kD, has a molecular diameter of approximately 4 nm; recombinant alkaline phosphatase (AP), with a molecular weight of approximately 80 kD, has a molecular diameter of approximately 5 nm. If the immune complex is formed as membrane-first receptor-analyte-second receptor-enzyme, the thickness of the immune complex (analyte-second receptor-enzyme) relative to the membrane-first receptor is only approximately 16 nm, far smaller than the membrane's pore diameter of 8 μm (8000 nm). The resulting enzyme-labeled immune complex will not block the membrane's internal channels, nor will it hinder the solution containing the enzyme-labeled second receptor from continuing to diffuse backward or downstream to react with binding sites on other downstream or subsequent test units, thereby being captured and immobilized by other downstream test units.
[0165] The above-mentioned pore size is that the film of 8 μ m is the actual pore size measured by electron microscope. In practical applications, the lateral flow rate of liquid in the film can be used as the criterion for judging the size of the membrane micropores. The size of the membrane pore size is inversely proportional to the time of the liquid lateral diffusion per unit distance in the membrane. The larger the pore size of the porous film, the faster the flow rate, and the smaller the pore size, the slower the flow rate. For example, the pore size is that the liquid lateral diffusion 4 cm in the membrane of 8 μ m takes about 140 seconds. When the actual time used is less than 140 seconds, it shows that the membrane pore size is less than 8 μ m. Otherwise, the pore size of the surface membrane is greater than 8 μ m.
[0166] In summary, the flow rate of the liquid is closely related to the properties of the substances contained in the liquid itself and the material of the porous membrane, especially the size of the pores. Limited experiments can be used to screen and obtain a suitable porous membrane to complete the entire testing process. The entire testing process here can be to allow the liquid sample to contact the sample receiving area 202, pass through the testing area, and flow to the water absorption area 100. Then, the solution of the second receptor containing the marker can be allowed to contact the sample receiving area 202 again, pass through the testing area, and flow to the water absorption area 100. Of course, during these reactions, a washing solution can be added, for example, one or two or more washings, and then the reaction solution containing the marker reaction can be allowed to contact the sample receiving area 202, pass through the testing area, and flow to the water absorption area 100. Of course, it is understood that a reaction solution is not required. For example, if the marker itself is colored, a reaction solution is not required, such as a water-soluble dye, gold particles, or latex particles.
[0167] Liquid-blocking components
[0168] Generally, multiple liquids can bind or capture the analyte during the flow of the porous membrane, or a second receptor carrying a labeled substance can also bind during the liquid flow. If it is necessary for the marker to contact the reaction solution to complete the reaction and generate a detection signal, the reaction solution can react with the marker during the flow. The sample solution, blocking solution, cleaning solution, the second receptor carrying the marker, and the reaction solution can all be received by one end of the porous membrane and then flow through the test area by capillary force to complete the analysis of the analyte.
[0169] In particular, in the present invention, the porous membrane is contacted with the liquid sample, the cleaning liquid, and the liquid of the second receptor with the marker, which can all pass through one end of the porous membrane 200 and rely on capillary force to flow laterally to the water absorption area to complete the entire test. In some cases, when the reaction liquid needs to react with the marker, although the reaction liquid can be allowed to pass through one end 200 of the porous membrane and rely on capillary force to flow laterally to the water absorption area, so that the reactants in the reaction liquid react with the marker and generate a signal, the signal represents the amount or quantity of the analyte. However, sometimes, some reactions require a longer time, such as 1-30 minutes of contact. Relying solely on the capillary force of the water absorption area may make the liquid flow faster and the reaction time shorter, and it may not fully react, resulting in insufficient reaction results, which ultimately affects the test results. In other words, relying on the solution to carry out the necessary reactions during the flow of the porous membrane does not result in better test results. Once the product is assembled, although the porous membrane has been optimized and various aspects have been improved, it is still desirable to allow the solution to stay more on the test area for a full reaction.
[0170] In particular, when the test area contains a large number of test units, the time it takes for the liquid to flow through the film test area under capillary action is not enough to complete the reaction between the reaction liquid and the marker substance to generate a signal, or during the reaction liquid flow process, it is not enough to consume all the markers fixed to the test units, which ultimately affects the accuracy of the test. In particular, when the analyte to be tested is large, and the test area on the porous film almost occupies the vast majority of the entire porous film area, the time it takes for the reaction liquid to flow from one end to the other end is at most 30 seconds to 1 minute, and no more than 2 minutes, for example, when the length of the porous film is 2 cm long. In this case, it is desirable that the liquid stays on the porous film for a certain period of time, especially on the test area on the porous film, so that the components in the liquid can fully react with the substances on the test units, thereby obtaining accurate results, and the stay time is preferably more than two minutes, for example, 2-30 minutes. For example, the substances in the reaction liquid are allowed to fully contact with the marker substance, fully react, and actually consume all the markers fixed to the test units, so that the marker is completely consumed, so that the signal generated can accurately reflect the amount of the analyte.
[0171] Therefore, in some embodiments, the device further includes a liquid-blocking element for blocking the liquid, allowing the liquid to stay on the porous film for a longer time or more time, particularly on the test area, so that the substance in the liquid (such as reaction liquid) and the substance on the porous film (the marker substance fixed on the test unit) are fully contacted and fully reacted. The longer time here is relative, and refers to when there is no liquid-blocking element, the liquid normally flows through the porous film with a certain flow rate, and the time spent is a fixed time, while under the liquid-blocking element, the flow rate of the liquid is slowed down by the blocking element, and at a certain distance, the time spent increases, thereby having more time for the active ingredient in the liquid to stay with the area on the porous film, such as the test area, the test reference area or the test result control area for a longer time. In particular, the reaction liquid is allowed to fully contact and effectively react with the marker fixed on the test area.
[0172] In some embodiments, the liquid-blocking element is a non-hygroscopic element distributed around the test area of the porous film. As shown in Figures 1A-1C, a liquid-blocking element 204 is provided at one end of the porous film, between the downstream of the test area and the water-absorbing area. The liquid-blocking element covers the porous film. The porous film is a flexible material, while the liquid-blocking element is non-hygroscopic and has a certain weight, exerting a certain pressure on the porous film. This allows the thickness of the porous film covered by the liquid-blocking element to be slightly reduced. This reduction directly affects the ability of the water-absorbing area to absorb liquid on the porous film. Naturally, the liquid flowing from the upstream of the test area has a slower flow rate due to the weakened absorption capacity, and the flow rate through the test area is slower, thereby allowing the liquid to contact the test area for a longer time.
[0173] In some embodiments, the liquid includes a reaction liquid, and the reaction liquid is allowed to stay on the test area for a long time, specifically the reaction of the substance in the reaction liquid with the marker substance on the test area. In some embodiments, when the reaction liquid contacts one end of the porous film, the capillary force of the water absorption area at the other end is relied upon to allow the reaction liquid to flow from one end of the porous film to the water absorption end, thereby passing through the test area. The liquid-blocking element is arranged near the water absorption area and on the porous film. In this way, when the porous film contacts the liquid, due to the arrangement of the liquid-blocking element, the liquid can flow into the water absorption area more slowly, and the liquid can stay on the porous film for a longer time. It is easy to understand that when there is no liquid-blocking element, the water-absorbing area and the porous membrane are naturally connected. If there is a liquid-blocking element on the porous membrane, it is equivalent to applying pressure to the porous membrane. This pressure can compress an area of the membrane, weakening or blocking the capillary action on the porous membrane that relies on the water-absorbing area to absorb liquid. This can increase the resistance to liquid flowing into the water-absorbing area, thereby slowing the speed at which the liquid naturally flows into the water-absorbing area and relatively prolonging the time it stays on the porous membrane, allowing it to fully stay in the test area of the porous membrane and undergo a more complete reaction. It can be understood that these liquid-blocking elements do not absolutely 100% restrict the flow of liquid on the porous membrane, but rather slow the flow rate of the liquid. When the porous film contacts the sample, the porous film is basically completely wetted and basically loses its capillary force, and its own water absorption performance is basically gone. At this time, if the subsequent liquid is allowed to continue to flow on the porous film, it mainly relies on the capillary force of the water absorption area to flow. If the flow rate is to be slowed down, it is actually to set a liquid-blocking element between the water absorption area and the porous film to slow down the flow rate of the subsequent liquid and prolong the time it stays on the porous film. Any known method is acceptable. The direction in which the liquid-blocking element is set is the direction of the flow rate, the upper limit of the flow rate, the process of the flow rate or the flow rate. It can be understood as a similar "dam" to prevent the flow of floods, thereby allowing water to gather in one place and slowing down the flow rate.
[0174] In some embodiments, the liquid barrier element is arranged to intersect with the direction of liquid flow, rather than being parallel. For example, as shown in Figures 1A-1C, the first liquid barrier element 204 is arranged near the water absorption area and on the porous film, and the second liquid barrier element 203 is arranged downstream of the liquid contact area 202. The first liquid barrier element 204 and the second liquid barrier element 203 are arranged in parallel, but both are perpendicular to the direction of liquid flow, and the test area is located between the first and second liquid barrier elements. In such an embodiment, only the first liquid barrier element 204 can be included, and the second liquid barrier element can be omitted. Generally, the liquid barrier element can be covered on the surface of the porous film, can be naturally covered without actually affecting the thickness of the porous film, or a certain pressure can be applied to the liquid barrier element to reduce the flow rate of the liquid flowing from the porous film to the water absorption area. The covering method can be to apply glue to the surface of the liquid barrier element, and then cover the surface of the porous film, and the glue allows the liquid barrier element to be fixed to the surface of the porous film. Of course, glue can also be not used, and the liquid barrier element can be fixed to the surface of the porous film directly by external pressure. When adopting the second liquid-blocking element 203, this liquid-blocking element is actually separating one end 202 of the porous film contacting liquid from the test area, and a purpose is exactly that the liquid that hopes to contact actually passes through the porous film, avoids flowing through from the surface of the porous film as far as possible.Like this, the upstream of the second liquid-blocking element 203 is exactly the zone that receives liquid, and this zone often needs to contact a variety of different liquids continuously, and sometimes the volume of liquid is bigger, and the second liquid-blocking element can allow liquid actually to flow to the test area downstream through the film covered by the liquid-blocking element, and has reduced direct flow directly from the film surface, has avoided torrent.In addition, as mentioned above, the liquid-blocking element itself may have pressure on the film, also allows the liquid from the zone 202 that receives liquid to enter the test area downstream at a slower speed, and the flow rate of liquid is slack. When the liquid-blocking element is attached to the porous film using a wave layer of glue, the glue itself actually seals the pores of the porous film, reducing the capillary force and allowing the liquid to flow faster on the porous film. This allows multiple test units on the porous film to come into contact with each liquid at a slower flow rate, allowing each test unit to fully react.
[0175] When applying reaction liquid, reaction liquid can be allowed to contact liquid receiving area 202, pass through porous film, pass through test area. In another way, reaction liquid 900 can also be directly added dropwise to the surface of porous film in a manner similar to that of FIG4B , a layer of reaction liquid can be covered on porous film, because barrier element has a certain thickness, reaction liquid can have a certain height on porous film, and the reactant in general reaction liquid is excessive, at this time, water absorption area can still keep attracting or absorbing the liquid on porous film due to the capillary force still keeping the porous film, and this capillary force continues to allow the liquid on porous film to flow to water absorption area, and the reaction liquid on porous film reacts with the marker on the test unit, so that reaction liquid can be allowed to stay on porous film for enough time, until reacting completely with the marker. Along with the reaction, until all reaction liquids are absorbed by water absorption area, that is, reaction liquid contacts with the marker while reacting, produces signal substance, while being attracted by the water absorption area at one end, so that reaction liquid can be allowed to keep for a period of time. The "short time" here can be 30 seconds, 1 minute, 2 minutes, 3 minutes, 5 minutes, 10 minutes, 15 minutes, 20 minutes, or 30 minutes. The dwell time is determined by the volume of the liquid applied. Furthermore, the dwell time is also determined by three important factors: whether the liquid-blocking element applies sufficient pressure to the porous film, and the water-absorbing capacity of the water-absorbing area. For example, the liquid-blocking element can have a thickness, and the thickness or height can be adjusted to control the volume of the reaction liquid. When the porous liquid-blocking element defines a certain area on the porous film, the height of the reaction liquid can naturally be adjusted.
[0176] In some ways, described liquid-blocking element surrounds the structure of a similar water reservoir on porous film, and liquid-blocking element surrounds a region on porous film surface, comprises test zone 205 in this region, can also comprise test control region, can also comprise a region or three regions in test reference region.For example as shown in Figure 2A, liquid-blocking element is covered on the surface of porous film 200 in the form of rectangular frame, forms a depressed region or region 2061 of similar water reservoir, the thickness of frame is as the height of water storage, and the end is exactly porous film, and what the other end is connected with porous film is water absorption region 100, wherein water absorbing material is set.Reaction solution can directly be applied in this water reservoir, allows reaction solution to be added dropwise in 2061 in this region, like this, reaction solution just directly diffuses in this region, and forms the reaction solution of certain height on porous film, thereby can allow reaction solution fully to react with labeling substance and produce the material of signal. The signal can be read. The "reading" here can be direct observation with the naked eye or reading through any device. For example, reading with the naked eye means observing the color change of the test unit or whether there is precipitation of colored substances. The device reading is generally electronic signal or fluorescence.
[0177] In some approaches, the labeling agent is an enzyme, including but not limited to horseradish peroxidase and alkaline phosphatase, or a small molecule compound, including but not limited to luminol, acridinium esters, fluorescein, rhodamine, or an oxidant. The signal generated can be a visible light absorption signal, a chemiluminescence signal, or a fluorescent signal. For example, a liquid containing 3,3',5,5'-tetramethylbenzidine that interacts with horseradish peroxidase and produces a chromophore deposition signal may include 3,3',5,5'-tetramethylbenzidine, 5-bromo-4-chloro-3-indolyl phosphate, tetrazolium nitro blue, luminol, adamantane, acridinium esters, and the like. Some react with horseradish peroxidase, some with alkaline phosphatase, and some are simply alkaline solutions.
[0178] In some embodiments, the liquid-blocking element is not arranged on a porous film alone, but relies on a window provided by an upper card, and the grid of the window covers the surface of the porous film. Such a mode can also form a liquid-blocking element alone. Of course, the grid of the window provided by the upper card can be used to cover the surface of the liquid-blocking element of the formed reservoir. On the one hand, a certain pressure can be applied to the liquid-blocking element, and on the other hand, the structure of the reservoir can be formed by combining the liquid-blocking element with the liquid-blocking element. Therefore, the liquid-blocking element generally selects a non-water-absorbing material, which can be plastic, metal, alloy, etc., which can all be used as a specific embodiment of the present invention. The element can be in the form of a sheet or strip.
[0179] For example, as shown in Figure 3, a test area 210 is provided on the porous film 200, a first liquid-blocking element 203 is covered on one end of the porous film, a second liquid-blocking element 204 is provided near the water-absorbing area, the porous film between the two liquid-blocking elements is a test area, a plurality of test cells 210 are provided in this area. This porous film is covered on the hard base film 211, and then the base film is placed in the groove 305 of the lower card together with the porous film. Described porous film and filter paper are all arranged in the cavity limited between the upper card 300 and the lower card 306. Between the upper card 300 and the lower card 306, a cavity is provided for accommodating the absorption area, which is the area for using the water-absorbing material in this cavity. In the specific embodiment shown in Figure 3, two water-absorbing materials 308 and 309 are stacked together and located in a cavity 307 formed by an upper card and a lower card. The lower water-absorbing block 308 is located in the cavity of the lower card, while the water-absorbing block 309 located above it is longer than the lower water-absorbing block, and the extended end 310 is in contact with one end 201 of the porous membrane. A window 303 is provided on the upper card. The glands constituting the window are rectangular glands, namely glands 302 and 313. The two glands distributed front and back cover the surfaces of the liquid-blocking elements 203 and 204, while the longitudinal glands 312 and 314 cover the porous membrane twice. In this way, a water reservoir structure is formed around the test area 210 of the porous membrane. Although the longitudinal glands 312 and 314 do not directly contact the surface of the porous membrane, the gap between them and the surface of the porous membrane is very small. Due to the surface tension of the liquid, basically no liquid will leak out. Therefore, when directly submitting liquid to the test area through window 303, liquid just directly spreads out and forms the liquid level with certain height in the test area, for example reaction solution, so liquid just covers on the test area, and the amount of liquid is relatively large, can allow the marker fixed on the test area all to react completely.When reacting, liquid can still be absorbed by the absorbing material connected thereto through the porous film covered by the first liquid-blocking element 204. After the reaction solution has been absorbed, the whole reaction also just reacts completely, allows the marker fixed on the test unit to react completely.In this embodiment, in fact, the lattice 312,314 of window also is the function that constitutes liquid-blocking element.After reaction finishes, the test result on the test area can be read through window 303.As described above, because the upper card and the lower card are when assembling, relying on the combined effect of assembling, can allow the lattice of window give liquid-blocking element a pressure, thereby give porous film a pressure.In some ways, the liquid-blocking element 203, 204 is not provided on the porous film, but the grid 302, 313 of the window is relied on, or the entire 4 grids 302, 314, 312, 313 are directly covered on the porous film, which is also feasible. However, this increases the difficulty of the processing technology of the window, and the surface of the film that needs to be in contact with it is very smooth, and you cannot give it much pressure. This method is feasible, but it is not the preferred method. Of course, it can also be the method as shown in Figures 4A and 4B, in which the entire porous film is exposed to the outside. At this time, the liquid-blocking element 204, 203 can be directly covered on the porous film 200, and the reaction liquid 900 is directly added to the test area, thereby relying on the barrier of the liquid-blocking element to allow the reaction liquid to contact the test area for a longer time and react more fully.
[0180] In another embodiment, the liquid barrier element of porous membrane is surrounded by the form of a pond of test zone, in the process of testing, when needs allow solution contact test zone time longer, can directly add solution in the pond, for example sample solution, cleaning solution, sealing solution, the second receptor solution with marker, reaction solution with marker reaction or other any solution that is beneficial to test.So, for the solution that does not need special reaction time, can directly allow sample contact end 202 to contact liquid, allow liquid to flow under the capillary force of film itself or water absorption zone through the porous membrane under liquid barrier element and just can complete a certain reaction.When a certain reaction needs longer time, then can directly add solution in the region that liquid barrier element surrounds, solution is spread out very soon in this region like this, then moistening whole film, allow the test unit in the test zone almost to contact solution simultaneously and react, along with the carrying out of reaction, the capillary force in water absorption zone continues to have water absorption capacity to porous membrane, solution also can be absorbed gradually, thereby solution similar has passed porous membrane and allows reaction more fully. In some embodiments, if the marker is an enzyme, a reagent solution that reacts with the enzyme can be directly added to the pool for reaction. As shown in FIG6 , the other structures are the same as those shown in FIG3 , except that the liquid-blocking element on the porous membrane is a frame structure 20 that covers the porous membrane. The liquid-blocking element forms a reservoir that allows liquid to be stored in the reservoir. The bottom of the reservoir is the porous membrane, and the window grid of the upper card covers the surface of the liquid-blocking element 20.
[0181] Specific implementation examples
[0182] The following describes how the device of the present invention works to achieve the purpose of the present invention through specific implementation examples. This is merely an example to illustrate how to implement the technical solution of the present invention, but does not limit the present invention in any way. The specific scope is subject to the claims.
[0183] Example 1: Detection of visible light signals and quantitative analysis of IgM antibodies using an immunoreaction chip with lateral diffusion detection
[0184] A micro-dispensing device (Hangzhou Bufeng Technology Co., Ltd.) was used to dispense CMV, HSV1, HSV2, RV, and TOX specific antigens (purchased from Shenzhen Feipeng Biological Co., Ltd.) onto the reaction area of the porous membrane of the immune response chip (nitrocellulose membrane was used this time, with a pore size of 10 μm, a membrane width of 13 mm, and a liquid barrier thickness of 0.8 mm, with a hard substrate underneath the membrane). The concentrations were 0.2 mg / mL and 50 nL / spot, respectively. The distance between each test unit or each antigen spot was 3 mm, and the cells were dried at 45°C for 2 hours. The membrane with the fixed antigen was loaded into a plastic card shell together with a water-absorbing block and fixed, allowing the water-absorbing block to connect to the porous membrane. A solid-phase chip reaction unit containing a liquid inlet area 202, a reaction area 205, and a liquid discharge area 100 was prepared (see Figure 3 for details).
[0185] For the convenience of description, the liquids involved in the immune response are numbered with Arabic numerals:
[0186] Solution #1: Recombinant anti-CAM IgM antibody, recombinant anti-HSV1 IgM antibody, recombinant anti-HSV2 IgM antibody, recombinant anti-RV IgM antibody, and recombinant anti-TOX IgM antibody (Shenzhen Feipeng Biotechnology Co., Ltd.) were diluted with phosphate buffer solution (pH 7.4) containing 10 mg / mL casein at dilution rates of 500, 2000, 8000, and 32000 to prepare sample solutions of different concentrations.
[0187] Solution #2: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0188] Solution #3: Working solution containing specific anti-human IgM and labeled with HRP (horseradish peroxidase).
[0189] Solution #4: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4.
[0190] Solution #5: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4.
[0191] #6: Reaction solution (Hangzhou Bufeng Technology Co., Ltd., containing 3,3',5,5'-tetramethylbenzidine)
[0192] The liquid inlet area 202 of the immune response chip element is sequentially contacted with #1 (sample solution), #2 (blocking solution), #3 (second receptor solution), #4 (cleaning solution), and #5 (cleaning solution), each solution is 5 ml, and each solution is in contact for 5 minutes. Each time a different liquid comes into contact with the liquid inlet area 202, it will diffuse through the test area of the porous membrane by virtue of the microporous channels of the nitrocellulose membrane itself, the surface tension between the liquid and the pores, and the capillary force provided by the liquid-absorbing material in the water-absorbing area.
[0193] After the contact with liquid #5 is complete, 200 μL of reaction liquid #6 is added dropwise directly to reaction area 205. The reaction liquid now covers the entire reaction area. However, it is blocked by the liquid barrier on the composite membrane and can only slowly diffuse out of the drainage area through the membrane's internal pores by capillary diffusion, where it is retained by the wicking material in contact. During this period, a spot signal appears in the reaction area until the substrate liquid is completely drained after 10 minutes, at which point the generated signal no longer changes significantly. Images were captured using an industrial microscope.
[0194] The test result images obtained by the above-mentioned shooting are shown in Figures 7A-7D. Within the appropriate concentration range, specific IgM antibodies to CMV, HSV1, HSV2, RV, and TOX specific antigens can all be detected. The test result images obtained by the above-mentioned shooting are shown in Figures 7A-7D. The intensity of the observable signal is positively correlated with the concentration of each analyte in the sample, indicating that the immune response chip element can also quantitatively detect the analytes in the sample. Figure 7A shows a sample diluted 500 times, Figure 1B shows a dilution of 2000 times, Figure 7C shows a dilution of 8000 times, and Figure 7D shows a dilution of 32000 times. From left to right, the colors on the test unit are from dark to light.
[0195] Because the primary reaction of the present invention is carried out on a porous membrane, the absorbent filter paper in the water-absorbing area exerts a continuous capillary force on the porous membrane, allowing different liquids to flow through the test area of the porous membrane, completing the entire testing process. The device itself possesses unidirectional diffusion and liquid storage capacity similar to that of an electronic diode, enabling the entire immune reaction to be completed without the various mechanical modules (fluidic module, mechanical vibration and movement device, magnetic separation and cleaning module, additional reaction cup storage and transfer module, waste liquid treatment system, system self-cleaning system, etc.) required by the current mainstream magnetic microparticle chemiluminescence method. This allows for the simplification of fully automated testing and minimizes energy consumption. The optical signal detector can be a photomultiplier tube (in this case, direct luminescent markers such as acridinium esters can also be used, further simplifying the detection process), a CCD (charge-coupled device), or a CMOS (complementary metal oxide semiconductor). Furthermore, due to the chip's ability to simultaneously detect multiple substances, multiple tests can be performed simultaneously, with any combination of different tests. This significantly improves detection efficiency. In this case, ultra-low-temperature cooled CCDs or CMOS are typically used. In addition to the chip structure and usage methods disclosed in the present invention, existing technologies can be utilized to obtain more accurate results. In addition, such a testing device is also particularly suitable for home self-testing. It can test multiple indicators at one time, and any indicators can be combined arbitrarily, such as multiple antigen indicators, multiple antibody indicators, etc.
[0196] Example 2: Detection of chemiluminescent signals of specific IgM antibodies to five antigens using an immunoreaction chip with lateral diffusion detection
[0197] Using a micro-dispensing device (Hangzhou Bufeng Technology Co., Ltd.), CMV, HSV1, HSV2, RV, and TOX-specific antigens (Shenzhen Feipeng Biotechnology Co., Ltd.) were applied to the membrane of an immunoreaction chip (nitrocellulose membrane with an 8 μm pore size, a 13 mm membrane width, and a 0.8 mm barrier thickness) at concentrations of 0.2 mg / mL, 0.2 mg / mL, 0.05 mg / mL, 0.2 mg / mL, and 0.05 mg / mL, respectively, at 50 nL / spot. The cells were dried at 45°C for 2 hours. The immobilized antigen membrane was loaded into a plastic cartridge along with a water-absorbing block and fixed. This produced a solid-phase chip reaction unit with a liquid inlet, reaction, and drainage areas (see Figure 3 for details).
[0198] For the convenience of description, the liquids involved in the immune response are numbered with Arabic numerals:
[0199] Solution #1: Recombinant anti-CAM IgM antibody, recombinant anti-HSV1 IgM antibody, recombinant anti-HSV2 IgM antibody, recombinant anti-RV IgM antibody, and recombinant anti-TOX IgM antibody (Shenzhen Feipeng Biotechnology Co., Ltd.) were diluted 3000-fold in phosphate buffer solution containing 10 mg / mL OsrHSA, 10 mg / mL Tween 20, pH 7.4 to prepare sample solutions of varying concentrations.
[0200] Solution #2: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0201] Solution #3: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0202] Solution #4: Enzyme working solution containing specific anti-human IgM-HRP (horseradish peroxidase) conjugate.
[0203] Solution #5: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4
[0204] Solution #6: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4
[0205] Liquid #7: Reaction solution (Hangzhou Bufeng Technology Co., Ltd., containing 3,3',5,5'-tetramethylbenzidine)
[0206] The liquid inlet region 202 of the solid-phase chip reaction unit was sequentially placed in contact with liquids #1, #2, #3, #4, #5, and #6 for 5 minutes each. Each time a different liquid came into contact with the liquid inlet region, it diffused through the reaction regions of the solid-phase chip reaction unit by capillary diffusion, leveraging the microporous channels of the nitrocellulose membrane, the surface tension between the liquid and the pores, and the wicking blocks in the liquid outlet region. After the contact period for liquid #6 expired, 200 μL of liquid #7 was added directly to the reaction region 205. Images were captured by the CCD at different exposure times. Images captured by the room-temperature CCD at different exposure times are shown in Figure 8.
[0207] Due to the rapid, glowing nature of enzymatic chemiluminescence, room-temperature CCD images of the chip at different exposure times were used to demonstrate that the observable signal of the analyte can be a chemiluminescent signal. This lays the foundation for the development of a new chemiluminescence technology platform and also indicates the feasibility of quantitative detection using chemiluminescence. Figures 8A-8C show the fluorescence signal intensity after exposure.
[0208] Example 3: Comparative test of the addition position of substrate solution or reaction solution
[0209] 1. Add location
[0210] Since the flow limiting function of the liquid barrier plate controls the constant volume of the reaction liquid in the reaction area, it ensures that all enzyme-containing immune complexes in the reaction area contact the substrate (reaction reagent) at the same time and generate an observable signal. The advantage of adding the substrate liquid directly to the reaction area is illustrated by comparing the changes in the signal intensity of the protein binding points (test units) after contacting the reaction liquid in the liquid inlet area 202 and directly adding the substrate liquid to the reaction area.
[0211] Using a micro-dispensing device (Hangzhou Bufeng Technology Co., Ltd.), CMV, HSV1, HSV2, RV, and TOX-specific antigens (Shenzhen Feipeng Biotechnology Co., Ltd.) were spotted onto the membrane of an immunoreaction chip (nitrocellulose membrane with a pore size of 10 μm, a membrane width of 13 mm, and a barrier film thickness of 0.8 mm) at a concentration of 0.2 mg / mL, 50 nL / spot, respectively. The cells were dried at 45°C for 2 hours. The antigen-immobilized membrane, along with a water-absorbing block, was loaded into a plastic cartridge and fixed. This created a solid-phase chip reaction unit with a liquid inlet, reaction, and drainage areas.
[0212] For the convenience of description, the liquids involved in the immune response are numbered with Arabic numerals:
[0213] Solution #1: Recombinant anti-CAM IgM antibody, recombinant anti-HSV 1 IgM antibody, recombinant anti-HSV 2 IgM antibody, recombinant anti-RV IgM antibody, and recombinant anti-TOX IgM antibody (Shenzhen Feipeng Biotechnology Co., Ltd.) were diluted 3000-fold in phosphate buffered saline (PBS) containing 10 mg / mL OsrHSA and 10 mg / mL Tween 20, pH 7.4.
[0214] Solution #2: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0215] Solution #3: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0216] Solution #4: Enzyme working solution containing specific anti-human IgM-HRP (horseradish peroxidase) conjugate.
[0217] Solution #5: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4
[0218] Solution #6: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4
[0219] Liquid #7: Reaction solution (Hangzhou Bufeng Technology Co., Ltd., containing 3,3',5,5'-tetramethylbenzidine)
[0220] The inlet area of the solid-phase chip reaction unit was sequentially exposed to #1, #2, #3, #4, #5, and #6 for 5 minutes each. Each time a different liquid came into contact with the inlet area, it diffused through the reaction area of the solid-phase chip reaction unit by capillary diffusion, leveraging the microporous channels of the nitrocellulose membrane, the surface tension between the liquid and the pores, and the wicking blocks in the drainage area. After the contact time with liquid #6 expired, inlet area 202 was exposed to 200 μL of liquid #7 (method 1) or 200 μL of substrate solution was added directly to the reaction area (method 2). The observable signal changes at each point in the reaction area for both methods were then captured using an industrial microscope at 10, 15, and 20 minutes, respectively.
[0221] The results are shown in Figure 9 (method 1) and Figure 10 (method 2). These results demonstrate that, because each point in the chip's reaction area in method 2 is simultaneously exposed to the substrate, the signal at each point reaches a maximum value in a shorter time. Method 1 shows significant results after 15 minutes, while method 2 produces excellent results in just 10 minutes.
[0222] 2. Adding reaction liquid to the reaction area will ensure that the liquid outlet will not be affected by the signal strength of the liquid inlet
[0223] By comparing the changes in protein binding site signal intensity after adding reaction liquid to the liquid inlet area 202 and directly adding reaction liquid to the reaction area, it is shown that no matter how strong the immune complex signal is at the liquid inlet end, it will not affect the strength of the immune complex signal on the same channel at the liquid outlet end.
[0224] Using a micro-dispensing device (Hangzhou Bufeng Technology Co., Ltd.), CMV, HSV1, HSV2, RV, and TOX-specific antigens (Shenzhen Feipeng Biotechnology Co., Ltd.) were spotted onto the membrane of an immunoreaction chip (nitrocellulose membrane with a pore size of 12 μm, a membrane width of 13 mm, and a barrier film thickness of 0.8 mm) at concentrations of 0.2 mg / mL, 0.2 mg / mL, 0.05 mg / mL, 0.2 mg / mL, and 0.05 mg / mL, respectively. 50 nL / spot was applied and dried at 45°C for 2 hours. The antigen-immobilized membrane was loaded into a plastic cartridge along with a water-absorbing block for securement. This created a solid-phase chip reaction unit with a liquid inlet, reaction, and drainage areas.
[0225] For the convenience of description, the liquids involved in the immune response are numbered with Arabic numerals:
[0226] Solution #1: Recombinant anti-CAM IgM antibody, recombinant anti-HSV 1 IgM antibody, recombinant anti-HSV 2 IgM antibody, recombinant anti-RV IgM antibody, and recombinant anti-TOX IgM antibody (Shenzhen Feipeng Biotechnology Co., Ltd.) were diluted in phosphate buffer solution containing 10 mg / mL OsrHSA, 10 mg / mL Tween 20, pH 7.4.
[0227] Solution #1-1: Only the TOX IgM antibody is diluted 8000-fold (under current conditions, the observable signal at this concentration is weak), while the remaining antibodies are diluted to 0 (under current conditions, the observable signal at this concentration is extremely weak or no signal).
[0228] #1 solution-2: Only the TOX IgM antibody was diluted 8000 times (under the current conditions, the observable signal at this concentration is weak), and the other antibodies were diluted 500 times (under the current conditions, the observable signal at this concentration is strong)
[0229] Solution #2: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0230] Solution #3: Phosphate buffer solution containing 10 mg / mL casein, pH 7.4.
[0231] Solution #4: Enzyme working solution containing specific anti-human IgM-HRP (horseradish peroxidase) conjugate.
[0232] Solution #5: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4
[0233] Solution #6: Phosphate buffer solution containing 1 mg / mL Tween 20, pH 7.4
[0234] Liquid #7: Reaction solution (Hangzhou Bufeng Technology Co., Ltd., containing 3,3',5,5'-tetramethylbenzidine)
[0235] The liquid inlet area of the solid-phase chip reaction unit is contacted with #1, #2, #3, #4, #5, and #6 for 5 minutes respectively. Each time a different liquid contacts the liquid inlet area, it will diffuse through the reaction area of the solid-phase chip reaction unit by relying on the microporous channels of the nitrocellulose membrane itself, the surface tension between the liquid and the pores, and the power provided by the water absorbent block in the drainage area.
[0236] After the contact time with solution #6 expired, the inlet area was contacted with 400 μL of solution #7 (method 1) or 200 μL of TMB solution #7 was added directly to the reaction area (method 2). For method 1, the TOX IgM detection signal intensities of solution #1-1 and solution #1-2 were compared at 25 minutes. For method 2, the TOX IgM detection signal intensities of solution #1-1 and solution #1-2 were compared at 10 minutes.
[0237] As shown in Figures 11 and 12, the detection of TOX IgM at the top, i.e., the outlet, is most significantly affected by the inlet. While this influence is significant, it is not excluded from the scope of the present invention and constitutes another approach. The observed signal intensity of the immune complex formed = [specific anti-TOX IgM concentration] × [specific anti-human IgM-HRP concentration] × [TMB-H2O2 concentration]. In this example, the specific anti-human IgM-HRP concentration in solution #4 and the TMB-H2O2 concentration in the TMB substrate solution were both near excess. By contrast, the detection results of TOX IgM using approach 2 were not affected by the inlet.
[0238] Example 4: Canine allergen testing device.
[0239] A device and solution reagent combination as shown in Figures 13 and 14 is provided, wherein the test device includes a porous membrane (the specific structure is introduced), and the solution reagent kit contains the reagents necessary for the reaction.
[0240] Preparation of solid phase reaction unit:
[0241] Using a micro-dispensing device (Hangzhou Bufeng Technology Co., Ltd.), mouse anti-goat monoclonal antibody (MAG), anti-canine IgE monoclonal antibody (anti-canine IgE Mab), and 74 allergens were spotted onto designated locations on a nitrocellulose membrane (10 μm pore size, 13 mm membrane width, and 0.8 mm barrier film thickness). The concentration of each substance was controlled between 100 ng / mL and 1.0 mg / mL. The diluent was phosphate buffered saline containing a red water-soluble dye at a rate of 50 nL / spot. The samples were dried at 45°C for 2 hours to fix the substances on the membrane.
[0242] The membrane and the liquid pipetting block are loaded into a plastic card shell and fixed (as shown in Figures 6 and 13), thereby preparing a solid-phase chip reaction unit containing a liquid inlet area, a reaction area, and a liquid outlet area.
[0243] The specific arrangement of the liquid dots on the porous film is shown in the following table (the first row and the first column on the left are the test result control units):
[0244] The chip reaction area after preparation is shown in Figure 13.
[0245] Preparative liquid phase reaction unit;
[0246] The following liquids were pre-added to the liquid phase reaction porous tank (Figure 15):
[0247] A sample diluent, 150 μL / well of a phosphate buffer solution at pH 7.4 containing Triton-X100, was pre-added to well 1.
[0248] Blocking solution, 300 μL / well of pH 7.4 phosphate buffer solution containing Casein-Na, bovine serum and Triton-X100, was pre-added to well 2.
[0249] Enzyme conjugate solution, i.e., enzyme working solution containing goat anti-dog IgE-HRP, was pre-added to well 3 at 300 μL / well.
[0250] Wash solution, phosphate buffer solution with pH 7.4 containing Tween 20, was pre-added to well 4 at 300 μL / well.
[0251] Wash solution, phosphate buffer solution with pH 7.4 containing Tween 20, was pre-added to well 5 at 300 μL / well.
[0252] The porous grooves are filled with liquid in advance and sealed with aluminum film by heat sealing, thereby protecting the liquid in each hole of the porous groove.
[0253] Reaction solution: 500 μL of reaction solution was stored in a sealed plastic bottle for later use.
[0254] Method for determination of IgE in dog serum:
[0255] Remove the liquid phase unit and place it flat on the work surface. Gently tap the porous trough to ensure that all pre-loaded liquid reagents return to the bottom of the trough. Pull the aluminum film away from the top surface of the trough until it is completely removed, exposing all the liquid. Add 150 μL of canine serum to well 1 and pipette repeatedly to thoroughly mix the sample and sample diluent.
[0256] Insert the liquid aspiration end 202 of the solid phase unit into the well 1 and let it stand. The liquid in the well 1 will automatically diffuse upwards, enter the porous membrane, and then flow through the test area.
[0257] After 7 minutes, the solid phase unit is removed from well 1 and moved to the top of well 2. The liquid aspiration end 202 of the solid phase unit is inserted into well 2 and allowed to stand. At this time, the liquid in well 2 will automatically diffuse from bottom to top.
[0258] After 7 minutes, remove the solid phase unit from well 2 and move it to the top of well 3. Insert the liquid aspiration end of the solid phase unit into well 3 and let it stand. The liquid in well 3 will automatically diffuse from bottom to top.
[0259] After 7 minutes, remove the solid phase unit from well 3 and move it to the top of well 4. Insert the liquid aspiration end of the solid phase unit into well 4 and let it stand. The liquid in well 4 will automatically diffuse from bottom to top.
[0260] After 7 minutes, the solid phase unit is taken out from hole 4 and moved to the top of hole 5. The liquid aspiration end of the solid phase unit is inserted into hole 5 and allowed to stand. At this time, the liquid in hole 5 will automatically diffuse from bottom to top.
[0261] After 7 minutes, remove the solid phase unit from hole 5 and place it flat on the workbench. Pour the reaction liquid into the stuck chip window. The substrate liquid will now spread flatly in the reaction area within the window and slowly diffuse into the water absorption area through the membrane under the liquid barrier element. After 10 minutes, the substrate liquid temporarily residing in the reaction area will be completely absorbed by the water absorption area. Observe the reaction area for the appearance of position points, total IgE points, and specific IgE spots within another 5 minutes.
[0262] The distribution of the points is rectangular. By comparing the horizontal and vertical points, the location of the spots is confirmed. The spot location corresponds to the specific allergen substance that triggers an immune reaction. This allows the presence of specific IgE in the serum that binds to the substance to be determined. The total IgE point is located at the bottom of the vertical points. Since this location is not on the same diffusion path as the allergen point, it does not affect the detection of specific IgE points.
[0263] FIG5B shows the test results of a dog serum sample, which shows that the sample contains specific IgE that reacts to the allergens Aspergillus fumigatus, Tyrophagus putrescentiae, wool, sheep dander, cockroach, anchovy, potato, and watermelon. The total IgE content in the sample is also high.
[0264] Such operation can be operated by hand, such as when testing at home. Of course, a machine can also be used to operate automatically, such as tearing off the solution tank sealing film, then adding the sample to No. 1 solution cavity, then inserting the washing liquid end 202 of the test card into No. 1 groove, putting it into a machine device, having a structure similar to that of a manipulator in the machine device and filling the test device card on which blotting paper is placed, start calculating the time, after the specific time, take out the test card from No. 1 groove, insert it into the subsequent solution cavity in sequence and react. After the last hole contact ends, the reaction solution can be taken out and directly added dropwise, or the reaction solution can be injected into 6 holes, allowing the reaction solution to flow into and pass through the test area from the porous film. Using such a machine device, continuous processing can be carried out in the laboratory. After the reaction ends, a reading device can also be automatically equipped, such as a photographing unit directly photographs the test area, directly processes the image, and directly outputs the result. Of course, the result of the test unit can also be seen by the naked eye.
[0265] Example 6: Effect of blocking reagent on test results
[0266] The specific method is the same as Example 5. When the sample is a negative sample, if a blocking reagent (such as the reagent in hole 2) is used, no color spots will appear on the test area. If there is no blocking reagent, color spots will appear on the test area, indicating that there are non-specific sites on each test unit, and also indicating that there is background in the blank area. The enzyme that can capture sheep anti-dog IgE-HRP produces a false positive structure. Moreover, there are also color precipitations between each test point, making the background not very clean and clear. Therefore, in the detection of multiple allergens, the blocking solution can solve non-specific binding, avoid false positives, and make the test background clean, reducing the impact of the background on the test area.
Claims
1. A device for detecting allergen antibodies in a liquid sample, include: A test area and a water absorbing area, wherein the test area is used to contact the liquid, and the water absorbing area is located downstream of the test area and is used to absorb the liquid from the test area, allowing the liquid to flow laterally through the test area and flow to the water absorbing area, wherein a plurality of different first receptors that specifically bind to allergen antibodies in the sample are fixed on the test area.
2. The device according to claim 1, wherein the test area is located on a porous film.
3. According to the device of claim 2, one end of the porous film is used to contact the liquid, and the other end of the porous film is in contact with the water absorption area, so that the water absorption area absorbs the liquid on the porous film, and the liquid flows from the end of the porous film that contacts the liquid through the test area to the other end that contacts the water absorption area.
4. The device according to claim 3, wherein the liquid comprises a dissolving solution for dissolving a liquid sample, a liquid containing a labeling substance, and at least two solutions selected from the group consisting of a washing liquid, a blocking liquid, and a reaction liquid.
5. The device according to claim 4, wherein the liquid containing the marker substance comprises a plurality of different second receptors that specifically bind to the allergen antibody (IgE) with the marker substance, wherein the second receptor can specifically bind to the allergen antibody (IgE) or a complex formed by the allergen antibody (IgE) and the first receptor 6. The device according to claim 5, wherein the second receptor comprises an antibody against an allergen antibody (IgE), and the first receptor comprises an allergen or an antibody against an allergen antibody (IgE).
7. The device according to claim 6, wherein the type of labeling substance carried by each of the second receptors is the same.
8. The device according to claim 7, wherein the types of the markers include enzymes, colored particles or dyes, or fluorescent markers.
9. The device according to claim 8, wherein the labeling substance is an enzyme.
10. The device according to claim 9, wherein the end of the porous film in contact with liquid can continuously contact at least two of the liquid samples, liquid containing markers, washing liquid, solution containing blocking reagents, and reaction liquids; or the end of the porous film in contact with liquid can continuously contact the liquid sample, the first washing liquid, the blocking reagent solution, the liquid containing markers, the second washing liquid, and the reaction liquid in sequence.
11. The device according to claim 10, further comprising a liquid-blocking element, which can allow the reaction liquid to stay on the test area on the porous film, or prevent the liquid from flowing from the surface of the film.
12. The device according to claim 11, wherein the liquid-blocking element is located between the test area and the end in contact with the liquid, or / and, the liquid-blocking element is located between the test area and the water absorption area, or / and, the liquid-blocking element is covered on a porous film.
13. The device according to claim 12, wherein the reaction solution contains a reaction reagent that can react with the enzyme to produce a readable signal.
14. The device according to claim 11, wherein the liquid-blocking element is located around the allergen array in the test area, so as to allow the reaction liquid to stay on the area where the allergen array is fixed.
15. The device according to claim 11, wherein the liquid-blocking element is located on a porous film to enclose a liquid pool area on the porous film, the test area is located in the area enclosed by the liquid-blocking element, and the reaction liquid can stay in the liquid pool.
16. The device according to claim 11, wherein the liquid-blocking element does not substantially affect the capillary force of the porous film, so that the absorption area can promote the reaction liquid on the porous film to flow into the water absorption area.
17. The device according to claim 11, wherein the liquid-blocking element is substantially composed of a hydrophobic polymer material, including one or more of polyvinyl chloride, polyester, polyurethane, and polystyrene.
18. The device according to claim 4, wherein the solution for dissolving the liquid sample does not contain a blocking reagent.
19. The device according to claim 18, wherein the blocking reagent is configured to block the porous and / or non-specific sites of the blank areas on the porous membrane.
20. The device of claim 18, wherein the blocking reagent comprises casein.
21. The device according to claim 2, wherein the porous film comprises a nitrocellulose membrane or a polyvinylidene fluoride membrane.
22. The device according to claim 3, in, The porous film is such that the time required for pure water to diffuse 4 cm along the porous film is less than 5 minutes.
23. A device as claimed in claim 1, wherein the water absorption area comprises a water absorption pad, and the water absorption pad comprises a hydrophilic fiber material selected from natural plant fibers or chemically synthesized acetate fibers.
24. A device as claimed in claim 1, wherein the liquid sample is a serum, plasma or whole blood sample.
25. A device as claimed in claim 1, further comprising a test reference area for testing allergen antibodies in the total sample.
26. A device as described in claim 1, wherein the first receptors are fixed on the test area in an array.
27. A method for detecting allergen antibodies in a liquid sample, the method comprising: include: A testing device is provided, the device comprising a testing area and a water absorption area, a plurality of first receptors are fixed in an array manner on the testing area, each receptor being capable of specifically binding to an allergen antibody in a liquid sample; The test area is located on a porous film having a first end and a second end. The water absorption area is connected to the first end of the porous film so that the second end of the porous film contacts the liquid sample, thereby allowing the liquid sample to pass through the test area on the porous film and then flow to the water absorption area.
28. The method according to claim 27, in, The second end of the porous membrane is contacted with a blocking liquid containing a blocking reagent, so that the blocking reagent fills the blank area on the porous membrane or blocks non-specific binding sites.
29. The method according to claim 28, wherein the second end of the porous membrane is contacted with a plurality of second receptor solutions containing a marker substance, each of the second receptors can specifically bind to an allergen antibody in the sample, thereby relying on the capillary action of the water absorption area to allow the second receptor solution containing the marker substance to pass through the test area and flow to the water absorption area.
30. The method according to claim 29, in, The porous film also includes an area formed by a liquid-blocking element, which includes the test area. The liquid-blocking element can allow the reaction liquid to stay on the test area.
31. The method according to claim 30, in, The reaction liquid is directly applied to the test area, so that the liquid-blocking element can keep the reaction liquid in the test area.
32. The method according to claim 31, in, The reaction solution includes a reaction reagent, and the reaction reagent can react with a labeling substance to generate a signal, and the presence or quantity of the analyzed substance can be obtained according to the presence or quantity of the signal.
33. The method according to claim 32, in, The signal can be read, preferably, by the naked eye.
34. The method according to claim 31, in, When the reaction liquid stays on the test area, the water absorption area can simultaneously absorb part of the reaction liquid on the porous film and flow to the water absorption area.
35. The method according to claim 34, in, The reaction solution is allowed to stay in the test area for 10 seconds to 60 minutes.
36. The method according to claim 27, in, After the second end of the porous film is contacted with the liquid sample, the first end of the porous film is contacted with the cleaning solution and then with the solution containing the marking substance.
Citation Information
Patent Citations
Multiplex detection immune chromatography chip
CN102375055A
A test strip for paper-based assay
CN107110860A
Device and method for measuring a great variety of matters to be analyzed
CN1500140A
Solid phase enzyme immunoassay test apparatus and process for detecting antibodies
EP0301141A1
Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots
US20050250141A1
